34166	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus	sodium fluoride	1	A01AA01	7	1
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	sodium fluoride	1	A01AA01	7	1
39338	Screening for cardiovascular disease and risk factors	sodium fluoride	1	A01AA01	7	1
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	hydrogen peroxide	1	A01AB02	7	0
34438	Care of the patient undergoing intracranial pressure monitoring/external ventricular drainage or lumbar drainage	chlorhexidine	4	A01AB03	7	1
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	chlorhexidine	16	A01AB03	7	1
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	miconazole	1	A01AB09	7	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	tetracycline	1	A01AB13	7	1
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	tetracycline	1	A01AB13	7	1
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	clotrimazole	1	A01AB18	7	1
32491	COPD management in the long-term care setting	doxycycline	1	A01AB22	7	1
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	doxycycline	1	A01AB22	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	dexamethasone	1	A01AC02	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	dexamethasone	1	A01AC02	7	1
47543	Diagnosis and treatment of osteoporosis	dexamethasone	1	A01AC02	7	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	dexamethasone	1	A01AC02	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	hydrocortisone	1	A01AC03	7	1
36825	Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\'s Multidisciplinary Consensus Conference	hydrocortisone	2	A01AC03	7	1
47572	Asthma. In: Pulmonary (acute &amp;amp; chronic)&lt;/div&gt;	hydrocortisone	1	A01AC03	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	epinephrine	1	A01AD01	7	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	epinephrine	1	A01AD01	7	1
35922	Consultation and referral guidelines citing the evidence: how the allergist/immunologist can help	epinephrine	1	A01AD01	7	1
37691	Allergen immunotherapy: a practice parameter third update	epinephrine	5	A01AD01	7	1
38255	Diagnosis and management of asthma	epinephrine	1	A01AD01	7	1
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	epinephrine	1	A01AD01	7	1
34087	Prevention of stroke. In: Canadian best practice recommendations for stroke care	acetylsalicylic acid	10	A01AD05	7	1
35922	Consultation and referral guidelines citing the evidence: how the allergist/immunologist can help	acetylsalicylic acid	1	A01AD05	7	1
36628	Clinical practice guideline for type 2 diabetes	acetylsalicylic acid	1	A01AD05	7	1
38898	Diabetes care	acetylsalicylic acid	1	A01AD05	7	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	acetylsalicylic acid	1	A01AD05	7	1
44088	Hyperphosphataemia in chronic kidney disease. Management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease	calcium carbonate	1	A02AC01	7	1
47543	Diagnosis and treatment of osteoporosis	calcium carbonate	2	A02AC01	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	cimetidine	1	A02BA01	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	cimetidine	1	A02BA01	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	ranitidine	2	A02BA02	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	ranitidine	1	A02BA02	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	famotidine	2	A02BA03	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	famotidine	1	A02BA03	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	nizatidine	1	A02BA04	7	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	misoprostol	1	A02BB01	7	1
47806	Medical management of adults with osteoarthritis	misoprostol	1	A02BB01	7	1
48530	VA/DoD clinical practice guideline for the non-surgical management of hip and knee osteoarthritis	misoprostol	1	A02BB01	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	omeprazole	1	A02BC01	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	pantoprazole	1	A02BC02	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	esomeprazole	1	A02BC05	7	1
34900	Late (complicated) Parkinson\'s disease	papaverine	1	A03AD01	7	1
33192	Acute coronary syndrome and myocardial infarction	atropine	4	A03BA01	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	metoclopramide	1	A03FA01	7	1
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	metoclopramide	1	A03FA01	7	1
34900	Late (complicated) Parkinson\'s disease	metoclopramide	1	A03FA01	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	metoclopramide	3	A03FA01	7	1
34900	Late (complicated) Parkinson\'s disease	domperidone	2	A03FA03	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	domperidone	1	A03FA03	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	domperidone	1	A03FA03	7	1
34900	Late (complicated) Parkinson\'s disease	ondansetron	1	A04AA01	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	ondansetron	1	A04AA01	7	1
34900	Late (complicated) Parkinson\'s disease	methylcellulose	1	A06AC06	7	1
38255	Diagnosis and management of asthma	magnesium sulfate	5	A06AD04	7	1
47572	Asthma. In: Pulmonary (acute &amp;amp; chronic)&lt;/div&gt;	magnesium sulfate	1	A06AD04	7	1
34900	Late (complicated) Parkinson\'s disease	lactulose	1	A06AD11	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	lactulose	3	A06AD11	7	1
34900	Late (complicated) Parkinson\'s disease	macrogol	1	A06AD15	7	
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	mannitol	2	A06AD16	7	1
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	mannitol	2	A06AD16	7	1
38254	Diagnosis and initial treatment of ischemic stroke	mannitol	2	A06AD16	7	1
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	nystatin	1	A07AA02	7	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	vancomycin	1	A07AA09	7	1
48368	Guidelines for laparoscopic peritoneal dialysis access surgery	vancomycin	1	A07AA09	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	pectin	1	A07BC01	7	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	prednisolone	2	A07EA01	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	prednisolone	1	A07EA01	7	1
36895	Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology	prednisolone	1	A07EA01	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	prednisolone	11	A07EA01	7	1
38410	Osteoporosis: assessing the risk of fragility fracture	prednisolone	2	A07EA01	7	1
32422	American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis	prednisone	12	A07EA03	7	1
32491	COPD management in the long-term care setting	prednisone	1	A07EA03	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	prednisone	1	A07EA03	7	1
34286	"Osteoporosis: diagnosis, treatment, and fracture prevention"	prednisone	3	A07EA03	7	1
35236	Osteoporosis: prevention and treatment	prednisone	1	A07EA03	7	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	prednisone	7	A07EA03	7	1
36874	Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline	prednisone	2	A07EA03	7	1
37827	Osteoporosis in men: an Endocrine Society clinical practice guideline	prednisone	1	A07EA03	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	prednisone	29	A07EA03	7	1
38897	Chronic obstructive pulmonary disease (COPD)	prednisone	2	A07EA03	7	1
39244	"Rheumatoid arthritis: diagnosis, management and monitoring"	prednisone	1	A07EA03	7	1
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	prednisone	3	A07EA03	7	1
47543	Diagnosis and treatment of osteoporosis	prednisone	5	A07EA03	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	prednisone	1	A07EA03	7	1
48212	The official positions of the International Society for Clinical Densitometry: vertebral fracture assessment	prednisone	1	A07EA03	7	1
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	prednisone	1	A07EA03	7	1
32491	COPD management in the long-term care setting	budesonide	1	A07EA06	7	1
38255	Diagnosis and management of asthma	budesonide	2	A07EA06	7	1
38897	Chronic obstructive pulmonary disease (COPD)	budesonide	1	A07EA06	7	1
47572	Asthma. In: Pulmonary (acute &amp;amp; chronic)&lt;/div&gt;	budesonide	1	A07EA06	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	sulfasalazine	2	A07EC01	7	1
34950	Management of early rheumatoid arthritis. A national clinical guideline	sulfasalazine	1	A07EC01	7	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	sulfasalazine	1	A07EC01	7	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	sulfasalazine	1	A07EC01	7	1
39244	"Rheumatoid arthritis: diagnosis, management and monitoring"	sulfasalazine	1	A07EC01	7	1
46240	Prevention and management of obesity for adults	phentermine	1	A08AA01	7	1
48461	VA/DoD clinical practice guideline for screening and management of overweight and obesity	phentermine	2	A08AA01	7	1
36628	Clinical practice guideline for type 2 diabetes	sibutramine	2	A08AA10	7	1
46240	Prevention and management of obesity for adults	lorcaserin	1	A08AA11	7	1
48461	VA/DoD clinical practice guideline for screening and management of overweight and obesity	lorcaserin	2	A08AA11	7	1
15597	Management of obesity. A national clinical guideline	orlistat	5	A08AB01	7	1
36628	Clinical practice guideline for type 2 diabetes	orlistat	1	A08AB01	7	1
37710	Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement	orlistat	3	A08AB01	7	1
43853	"Prevention of chronic disease. In: Guidelines for preventive activities in general practice, 8th edition"	orlistat	1	A08AB01	7	1
46240	Prevention and management of obesity for adults	orlistat	2	A08AB01	7	1
47568	World Gastroenterology Organisation global guideline: obesity	orlistat	5	A08AB01	7	1
48052	"Clinical practice guidelines for the management of overweight and obesity in adults, adolescents and children in Australia"	orlistat	1	A08AB01	7	1
48461	VA/DoD clinical practice guideline for screening and management of overweight and obesity	orlistat	2	A08AB01	7	1
48872	"Obesity: identification, assessment and management of overweight and obesity in children, young people and adults"	orlistat	8	A08AB01	7	1
49013	Recommendations for prevention of weight gain and use of behavioural and pharmacological interventions to manage overweight and obesity in adults in primary care	orlistat	2	A08AB01	7	1
36628	Clinical practice guideline for type 2 diabetes	rimonabant	1	A08AX01	7	1
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	insulin lispro	1	A10AB04	7	1
47898	Diabetes and pregnancy: an Endocrine Society clinical practice guideline	insulin lispro	1	A10AB04	7	1
48544	Diagnosis and management of type 2 diabetes mellitus in adults	insulin lispro	1	A10AB04	7	1
45527	Diabetes management in the long term care setting	insulin aspart	1	A10AB05	7	1
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	insulin aspart	1	A10AB05	7	1
47898	Diabetes and pregnancy: an Endocrine Society clinical practice guideline	insulin aspart	1	A10AB05	7	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	insulin glargine	1	A10AE04	7	1
34113	Cardiometabolic risk management guidelines in primary care	insulin glargine	1	A10AE04	7	1
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	insulin glargine	1	A10AE04	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	insulin glargine	3	A10AE04	7	1
47898	Diabetes and pregnancy: an Endocrine Society clinical practice guideline	insulin glargine	2	A10AE04	7	1
48544	Diagnosis and management of type 2 diabetes mellitus in adults	insulin glargine	1	A10AE04	7	1
47898	Diabetes and pregnancy: an Endocrine Society clinical practice guideline	insulin detemir	3	A10AE05	7	1
15711	Clinical practice guideline on the management of lipids as a cardiovascular risk factor	metformin	1	A10BA02	7	1
16394	Management of diabetes. A national clinical guideline	metformin	12	A10BA02	7	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	metformin	6	A10BA02	7	1
25679	Liraglutide for the treatment of type 2 diabetes mellitus	metformin	5	A10BA02	7	1
34113	Cardiometabolic risk management guidelines in primary care	metformin	1	A10BA02	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	metformin	1	A10BA02	7	1
35257	Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians	metformin	13	A10BA02	7	1
36628	Clinical practice guideline for type 2 diabetes	metformin	7	A10BA02	7	1
36888	Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes	metformin	5	A10BA02	7	1
37710	Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement	metformin	2	A10BA02	7	1
38898	Diabetes care	metformin	1	A10BA02	7	1
39354	European guidelines on cardiovascular disease prevention in clinical practice (version 2012)	metformin	1	A10BA02	7	1
39539	Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents	metformin	8	A10BA02	7	1
45527	Diabetes management in the long term care setting	metformin	4	A10BA02	7	1
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	metformin	2	A10BA02	7	1
46926	Dapagliflozin in combination therapy for treating type 2 diabetes	metformin	2	A10BA02	7	1
47068	Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes	metformin	10	A10BA02	7	1
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	metformin	1	A10BA02	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	metformin	2	A10BA02	7	1
47898	Diabetes and pregnancy: an Endocrine Society clinical practice guideline	metformin	2	A10BA02	7	1
48544	Diagnosis and management of type 2 diabetes mellitus in adults	metformin	17	A10BA02	7	1
49013	Recommendations for prevention of weight gain and use of behavioural and pharmacological interventions to manage overweight and obesity in adults in primary care	metformin	2	A10BA02	7	1
49124	Empagliflozin in combination therapy for treating type 2 diabetes	metformin	3	A10BA02	7	1
16394	Management of diabetes. A national clinical guideline	glibenclamide	1	A10BB01	7	
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	glibenclamide	1	A10BB01	7	
47898	Diabetes and pregnancy: an Endocrine Society clinical practice guideline	glibenclamide	1	A10BB01	7	
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	chlorpropamide	1	A10BB02	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	glipizide	1	A10BB07	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	gliclazide	1	A10BB09	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	glimepiride	1	A10BB12	7	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	acarbose	1	A10BF01	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	acarbose	1	A10BF01	7	1
36628	Clinical practice guideline for type 2 diabetes	acarbose	2	A10BF01	7	1
38898	Diabetes care	acarbose	1	A10BF01	7	1
16394	Management of diabetes. A national clinical guideline	rosiglitazone	4	A10BG02	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	rosiglitazone	1	A10BG02	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	rosiglitazone	1	A10BG02	7	1
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	rosiglitazone	1	A10BG02	7	1
16394	Management of diabetes. A national clinical guideline	pioglitazone	4	A10BG03	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	pioglitazone	1	A10BG03	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	pioglitazone	1	A10BG03	7	1
36628	Clinical practice guideline for type 2 diabetes	pioglitazone	3	A10BG03	7	1
24712	Treatment of dyslipidaemias	guar gum	1	A10BX01	7	0
39404	Critical illness evidence-based nutrition practice guideline	guar gum	2	A10BX01	7	0
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	repaglinide	1	A10BX02	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	nateglinide	1	A10BX03	7	1
16394	Management of diabetes. A national clinical guideline	exenatide	1	A10BX04	7	1
25679	Liraglutide for the treatment of type 2 diabetes mellitus	exenatide	2	A10BX04	7	1
36888	Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes	exenatide	4	A10BX04	7	1
16394	Management of diabetes. A national clinical guideline	liraglutide	2	A10BX07	7	1
25679	Liraglutide for the treatment of type 2 diabetes mellitus	liraglutide	7	A10BX07	7	1
36888	Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes	liraglutide	2	A10BX07	7	1
46926	Dapagliflozin in combination therapy for treating type 2 diabetes	dapagliflozin	4	A10BX09	7	1
49124	Empagliflozin in combination therapy for treating type 2 diabetes	empagliflozin	4	A10BX12	7	1
14329	Identification and management of familial hypercholesterolaemia	vitamins	1	A11	3	0
24712	Treatment of dyslipidaemias	vitamins	1	A11	3	0
24713	Coronary heart disease	vitamins	2	A11	3	0
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	vitamins	2	A11	3	0
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	vitamins	1	A11	3	0
39404	Critical illness evidence-based nutrition practice guideline	vitamins	1	A11	3	0
39405	Food and nutrition for older adults promoting health and wellness (FNOA)	vitamins	1	A11	3	0
43766	"Preventive activities prior to pregnancy. In: Guidelines for preventive activities in general practice, 8th edition"	vitamins	1	A11	3	0
43916	Age-related changes in health. In: Evidence-based geriatric nursing protocols for best practice	vitamins	1	A11	3	0
46240	Prevention and management of obesity for adults	vitamins	1	A11	3	0
46241	Stable coronary artery disease	vitamins	1	A11	3	0
46910	2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult	vitamins	1	A11	3	0
47538	A.S.P.E.N. clinical guidelines: nutrition support of hospitalized adult patients with obesity	vitamins	1	A11	3	0
47568	World Gastroenterology Organisation global guideline: obesity	vitamins	1	A11	3	0
47783	Lipid management in adults	vitamins	2	A11	3	0
47898	Diabetes and pregnancy: an Endocrine Society clinical practice guideline	vitamins	1	A11	3	0
48221	Secondary prevention of ischemic heart disease and stroke in adults	vitamins	2	A11	3	0
48872	"Obesity: identification, assessment and management of overweight and obesity in children, young people and adults"	vitamins	3	A11	3	0
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	multivitamins with minerals	1	A11AA	5	1
47543	Diagnosis and treatment of osteoporosis	calcitriol	3	A11CC04	7	1
48951	VA/DoD clinical practice guideline for the management of chronic kidney disease in primary care	calcitriol	1	A11CC04	7	1
47538	A.S.P.E.N. clinical guidelines: nutrition support of hospitalized adult patients with obesity	thiamine	1	A11DA01	7	1
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	ascorbic acid	1	A11GA01	7	1
37288	Guidelines for the prevention and management of &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; infection and disease in adult patients with chronic kidney disease	pyridoxine	2	A11HA02	7	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	tocopherol	1	A11HA03	7	1
47568	World Gastroenterology Organisation global guideline: obesity	mineral supplements	1	A12	3	1
25316	Screening for osteoporosis: U.S. Preventive Services Task Force recommendation statement	calcium supplements	1	A12A	4	1
34968	American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis	calcium supplements	1	A12A	4	1
37827	Osteoporosis in men: an Endocrine Society clinical practice guideline	calcium supplements	1	A12A	4	1
43860	"Osteoporosis. In: Guidelines for preventive activities in general practice, 8th edition"	calcium supplements	1	A12A	4	1
47543	Diagnosis and treatment of osteoporosis	calcium supplements	1	A12A	4	1
10584	Management of stable angina. A national clinical guideline	calcium	3	A12AA	5	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	calcium	1	A12AA	5	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	calcium	11	A12AA	5	1
16392	Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin	calcium	4	A12AA	5	1
16394	Management of diabetes. A national clinical guideline	calcium	1	A12AA	5	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	calcium	1	A12AA	5	1
23824	ACR Appropriateness Criteria&amp;reg; osteoporosis and bone mineral density	calcium	5	A12AA	5	1
23899	"Prevention of ventricular remodeling, cardiac dysfunction, and heart failure: HFSA 2010 comprehensive heart failure practice guideline"	calcium	1	A12AA	5	1
23900	Evaluation of patients for ventricular dysfunction and heart failure: HFSA 2010 comprehensive heart failure practice guideline	calcium	1	A12AA	5	1
23907	Evaluation and management of patients with heart failure and preserved left ventricular ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	calcium	1	A12AA	5	1
23909	Evaluation and therapy for heart failure in the setting of ischemic heart disease: HFSA 2010 comprehensive heart failure practice guideline	calcium	3	A12AA	5	1
23910	Managing patients with hypertension and heart failure: HFSA 2010 comprehensive heart failure practice guideline	calcium	2	A12AA	5	1
23924	Chronic kidney disease evidence-based nutrition practice guideline	calcium	9	A12AA	5	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	calcium	1	A12AA	5	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	calcium	2	A12AA	5	1
24713	Coronary heart disease	calcium	1	A12AA	5	1
25310	2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	calcium	2	A12AA	5	1
25311	Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society clinical practice guideline	calcium	2	A12AA	5	1
25316	Screening for osteoporosis: U.S. Preventive Services Task Force recommendation statement	calcium	2	A12AA	5	1
32422	American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis	calcium	4	A12AA	5	1
32492	Heart failure in the long-term care setting	calcium	2	A12AA	5	1
32645	ACR Appropriateness Criteria&amp;reg; cerebrovascular disease	calcium	1	A12AA	5	1
33192	Acute coronary syndrome and myocardial infarction	calcium	2	A12AA	5	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	calcium	1	A12AA	5	1
34113	Cardiometabolic risk management guidelines in primary care	calcium	7	A12AA	5	1
34277	"Dietary guidelines for Americans, 2010"	calcium	1	A12AA	5	1
34286	"Osteoporosis: diagnosis, treatment, and fracture prevention"	calcium	14	A12AA	5	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	calcium	1	A12AA	5	1
34444	Clinical practice guideline for dementia. Part I: diagnosis &amp;amp; evaluation	calcium	2	A12AA	5	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	calcium	1	A12AA	5	1
34824	Hypertension. Clinical management of primary hypertension in adults	calcium	4	A12AA	5	1
34825	Management of stable angina	calcium	12	A12AA	5	1
34968	American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis	calcium	2	A12AA	5	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	calcium	1	A12AA	5	1
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	calcium	1	A12AA	5	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	calcium	3	A12AA	5	1
35131	HealthPartners Dental Group and Clinics periodontal risk assessment guideline	calcium	1	A12AA	5	1
35236	Osteoporosis: prevention and treatment	calcium	1	A12AA	5	1
36628	Clinical practice guideline for type 2 diabetes	calcium	1	A12AA	5	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	calcium	1	A12AA	5	1
36906	Prevention of falls (acute care). Health care protocol	calcium	1	A12AA	5	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	calcium	1	A12AA	5	1
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	calcium	1	A12AA	5	1
37827	Osteoporosis in men: an Endocrine Society clinical practice guideline	calcium	5	A12AA	5	1
38413	Osteoporosis	calcium	1	A12AA	5	1
38470	EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia	calcium	1	A12AA	5	1
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	calcium	1	A12AA	5	1
38684	A.S.P.E.N. clinical guidelines: nutrition support in adult acute and chronic renal failure	calcium	1	A12AA	5	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	calcium	1	A12AA	5	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	calcium	1	A12AA	5	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	calcium	4	A12AA	5	1
39338	Screening for cardiovascular disease and risk factors	calcium	2	A12AA	5	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	calcium	2	A12AA	5	1
39354	European guidelines on cardiovascular disease prevention in clinical practice (version 2012)	calcium	2	A12AA	5	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	calcium	2	A12AA	5	1
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	calcium	5	A12AA	5	1
39382	Taiwan osteoporosis practice guidelines	calcium	20	A12AA	5	1
43766	"Preventive activities prior to pregnancy. In: Guidelines for preventive activities in general practice, 8th edition"	calcium	1	A12AA	5	1
43854	"Prevention of vascular and metabolic disease. In: Guidelines for preventive activities in general practice, 8th edition"	calcium	1	A12AA	5	1
43860	"Osteoporosis. In: Guidelines for preventive activities in general practice, 8th edition"	calcium	3	A12AA	5	1
43916	Age-related changes in health. In: Evidence-based geriatric nursing protocols for best practice	calcium	2	A12AA	5	1
44088	Hyperphosphataemia in chronic kidney disease. Management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease	calcium	22	A12AA	5	1
46240	Prevention and management of obesity for adults	calcium	1	A12AA	5	1
46241	Stable coronary artery disease	calcium	10	A12AA	5	1
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	calcium	1	A12AA	5	1
46648	Diagnosis and management of adults with chronic kidney disease	calcium	1	A12AA	5	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	calcium	3	A12AA	5	1
46910	2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult	calcium	1	A12AA	5	1
47030	Heart failure in adults	calcium	2	A12AA	5	1
47108	Adults with systolic heart failure	calcium	1	A12AA	5	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	calcium	5	A12AA	5	1
47543	Diagnosis and treatment of osteoporosis	calcium	44	A12AA	5	1
47568	World Gastroenterology Organisation global guideline: obesity	calcium	1	A12AA	5	1
47572	Asthma. In: Pulmonary (acute &amp;amp; chronic)&lt;/div&gt;	calcium	1	A12AA	5	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	calcium	3	A12AA	5	1
47804	Management and prevention of osteoporosis	calcium	3	A12AA	5	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	calcium	1	A12AA	5	1
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	calcium	2	A12AA	5	1
48117	Guidelines for the management of absolute cardiovascular disease risk	calcium	2	A12AA	5	1
48196	Essential hypertension	calcium	1	A12AA	5	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	calcium	1	A12AA	5	1
48267	2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	calcium	1	A12AA	5	1
48280	ACR Appropriateness Criteria&amp;reg; chest pain suggestive of acute coronary syndrome	calcium	3	A12AA	5	1
48333	Atrial fibrillation: the management of atrial fibrillation	calcium	3	A12AA	5	1
48337	2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	calcium	1	A12AA	5	1
48340	2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	calcium	1	A12AA	5	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	calcium	5	A12AA	5	1
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	calcium	1	A12AA	5	1
48950	VA/DoD clinical practice guideline for the management of dyslipidemia for cardiovascular risk reduction	calcium	1	A12AA	5	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	calcium	4	A12AA	5	1
47543	Diagnosis and treatment of osteoporosis	calcium citrate	1	A12AA13	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	potassium supplements	1	A12B	4	1
34824	Hypertension. Clinical management of primary hypertension in adults	potassium supplements	1	A12B	4	1
10587	Management of chronic heart failure. A national clinical guideline	potassium	2	A12BA	5	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	potassium	4	A12BA	5	1
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	potassium	6	A12BA	5	1
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	potassium	3	A12BA	5	1
23924	Chronic kidney disease evidence-based nutrition practice guideline	potassium	6	A12BA	5	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	potassium	2	A12BA	5	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	potassium	5	A12BA	5	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	potassium	1	A12BA	5	1
34113	Cardiometabolic risk management guidelines in primary care	potassium	2	A12BA	5	1
34277	"Dietary guidelines for Americans, 2010"	potassium	1	A12BA	5	1
34824	Hypertension. Clinical management of primary hypertension in adults	potassium	4	A12BA	5	1
34837	Hyperglycaemia in acute coronary syndromes. Management of hyperglycaemia in acute coronary syndromes	potassium	1	A12BA	5	1
36628	Clinical practice guideline for type 2 diabetes	potassium	1	A12BA	5	1
37694	Assessing heart failure in long term care facilities	potassium	1	A12BA	5	1
38684	A.S.P.E.N. clinical guidelines: nutrition support in adult acute and chronic renal failure	potassium	1	A12BA	5	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	potassium	1	A12BA	5	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	potassium	1	A12BA	5	1
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	potassium	3	A12BA	5	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	potassium	3	A12BA	5	1
47030	Heart failure in adults	potassium	8	A12BA	5	1
47108	Adults with systolic heart failure	potassium	1	A12BA	5	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	potassium	3	A12BA	5	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	potassium	2	A12BA	5	1
47865	Clinical practice guideline for diabetes mellitus type 1	potassium	1	A12BA	5	1
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	potassium	1	A12BA	5	1
48117	Guidelines for the management of absolute cardiovascular disease risk	potassium	1	A12BA	5	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	potassium	1	A12BA	5	1
48544	Diagnosis and management of type 2 diabetes mellitus in adults	potassium	2	A12BA	5	1
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	potassium	1	A12BA	5	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	potassium	2	A12BA	5	1
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	sodium supplements	1	A12CA	5	1
39430	KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease	sodium chloride	1	A12CA01	7	1
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	sodium chloride	1	A12CA01	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	magnesium supplements	1	A12CC	5	1
23902	Nonpharmacologic management and health care maintenance of patients with chronic heart failure: HFSA 2010 comprehensive heart failure practice guideline	anabolic steroids	1	A14A	4	1
39404	Critical illness evidence-based nutrition practice guideline	glutamine	12	A16AA03	7	0
34085	Public awareness of stroke. In: Canadian best practice recommendations for stroke care	antithrombotic agents	1	B01	3	1
34087	Prevention of stroke. In: Canadian best practice recommendations for stroke care	antithrombotic agents	1	B01	3	1
34090	Acute stroke management. In: Canadian best practice recommendations for stroke care	antithrombotic agents	1	B01	3	1
34091	Stroke rehabilitation. In: Canadian best practice recommendations for stroke care	antithrombotic agents	1	B01	3	1
34092	Managing stroke care transitions. In: Canadian best practice recommendations for stroke care	antithrombotic agents	1	B01	3	1
34094	Cross-continuum topics in stroke management. In: Canadian best practice recommendations for stroke care	antithrombotic agents	1	B01	3	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	antithrombotic agents	2	B01	3	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	antithrombotic agents	1	B01	3	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	vitamin k antagonists	1	B01AA	5	1
35269	"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	vitamin k antagonists	1	B01AA	5	1
38367	Antithrombotics: indications and management. A national clinical guideline	vitamin k antagonists	2	B01AA	5	1
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	vitamin k antagonists	2	B01AA	5	1
48333	Atrial fibrillation: the management of atrial fibrillation	vitamin k antagonists	2	B01AA	5	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	warfarin	2	B01AA03	7	1
14328	Stroke. Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA)	warfarin	1	B01AA03	7	1
14329	Identification and management of familial hypercholesterolaemia	warfarin	1	B01AA03	7	1
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	warfarin	4	B01AA03	7	1
24513	Warfarin therapy management	warfarin	32	B01AA03	7	1
24712	Treatment of dyslipidaemias	warfarin	2	B01AA03	7	1
33192	Acute coronary syndrome and myocardial infarction	warfarin	5	B01AA03	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	warfarin	11	B01AA03	7	1
34087	Prevention of stroke. In: Canadian best practice recommendations for stroke care	warfarin	15	B01AA03	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	warfarin	1	B01AA03	7	1
34978	Guidelines on oral anticoagulation with warfarin - fourth edition	warfarin	36	B01AA03	7	1
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	warfarin	1	B01AA03	7	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	warfarin	1	B01AA03	7	1
35262	"Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	warfarin	1	B01AA03	7	1
35269	"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	warfarin	1	B01AA03	7	1
35270	"Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	warfarin	2	B01AA03	7	1
35273	"Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	warfarin	12	B01AA03	7	1
36887	Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation	warfarin	2	B01AA03	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	warfarin	1	B01AA03	7	1
38254	Diagnosis and initial treatment of ischemic stroke	warfarin	4	B01AA03	7	1
38367	Antithrombotics: indications and management. A national clinical guideline	warfarin	23	B01AA03	7	1
38697	Recommendations for optimal warfarin management for prevention of thromboembolic events in patients with atrial fibrillation	warfarin	13	B01AA03	7	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	warfarin	5	B01AA03	7	1
39222	2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management	warfarin	2	B01AA03	7	1
39247	"2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design"	warfarin	5	B01AA03	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	warfarin	4	B01AA03	7	1
43837	Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation	warfarin	2	B01AA03	7	1
43854	"Prevention of vascular and metabolic disease. In: Guidelines for preventive activities in general practice, 8th edition"	warfarin	1	B01AA03	7	1
45138	Recommendations for antithrombotic agents for the prevention of stroke and systemic embolism in patients with atrial fibrillation	warfarin	7	B01AA03	7	1
47315	Adult depression in primary care	warfarin	1	B01AA03	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	warfarin	2	B01AA03	7	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	warfarin	3	B01AA03	7	1
47783	Lipid management in adults	warfarin	6	B01AA03	7	1
47806	Medical management of adults with osteoarthritis	warfarin	2	B01AA03	7	1
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	warfarin	2	B01AA03	7	1
47873	Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation. Report of the Guideline Development Subcommittee of the American Academy of Neurology	warfarin	11	B01AA03	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	warfarin	4	B01AA03	7	1
48261	Management of acute atrial fibrillation and atrial flutter in non-pregnant hospitalized adults	warfarin	2	B01AA03	7	1
48267	2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	warfarin	8	B01AA03	7	1
48333	Atrial fibrillation: the management of atrial fibrillation	warfarin	6	B01AA03	7	1
35269	"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	phenprocoumon	1	B01AA04	7	1
47873	Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation. Report of the Guideline Development Subcommittee of the American Academy of Neurology	acenocoumarol	2	B01AA07	7	1
10585	Acute coronary syndromes. A national clinical guideline	heparin	1	B01AB01	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	heparin	4	B01AB01	7	1
14328	Stroke. Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA)	heparin	1	B01AB01	7	1
14329	Identification and management of familial hypercholesterolaemia	heparin	1	B01AB01	7	1
16393	Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction	heparin	7	B01AB01	7	1
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	heparin	2	B01AB01	7	1
24174	Managing complications. In: Clinical guidelines for stroke management 2010	heparin	4	B01AB01	7	1
24513	Warfarin therapy management	heparin	1	B01AB01	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	heparin	5	B01AB01	7	1
33192	Acute coronary syndrome and myocardial infarction	heparin	4	B01AB01	7	1
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	heparin	3	B01AB01	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	heparin	9	B01AB01	7	1
34087	Prevention of stroke. In: Canadian best practice recommendations for stroke care	heparin	1	B01AB01	7	1
34090	Acute stroke management. In: Canadian best practice recommendations for stroke care	heparin	2	B01AB01	7	1
34978	Guidelines on oral anticoagulation with warfarin - fourth edition	heparin	2	B01AB01	7	1
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	heparin	3	B01AB01	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	heparin	9	B01AB01	7	1
35262	"Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	heparin	4	B01AB01	7	1
35269	"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	heparin	18	B01AB01	7	1
35270	"Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	heparin	3	B01AB01	7	1
35271	"Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	heparin	2	B01AB01	7	1
35272	"Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	heparin	5	B01AB01	7	1
36825	Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\'s Multidisciplinary Consensus Conference	heparin	5	B01AB01	7	1
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	heparin	1	B01AB01	7	1
38254	Diagnosis and initial treatment of ischemic stroke	heparin	25	B01AB01	7	1
38367	Antithrombotics: indications and management. A national clinical guideline	heparin	10	B01AB01	7	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	heparin	1	B01AB01	7	1
39222	2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management	heparin	1	B01AB01	7	1
39247	"2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design"	heparin	6	B01AB01	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	heparin	5	B01AB01	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	heparin	4	B01AB01	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	heparin	7	B01AB01	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	heparin	1	B01AB01	7	1
47019	Myocardial infarction with ST-segment elevation. The acute management of myocardial infarction with ST-segment elevation	heparin	2	B01AB01	7	1
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	heparin	2	B01AB01	7	1
48267	2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	heparin	3	B01AB01	7	1
48333	Atrial fibrillation: the management of atrial fibrillation	heparin	2	B01AB01	7	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	heparin	2	B01AB01	7	1
33192	Acute coronary syndrome and myocardial infarction	dalteparin	1	B01AB04	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	dalteparin	1	B01AB04	7	1
33192	Acute coronary syndrome and myocardial infarction	enoxaparin	2	B01AB05	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	enoxaparin	2	B01AB05	7	1
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	enoxaparin	8	B01AB05	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	enoxaparin	8	B01AB05	7	1
38254	Diagnosis and initial treatment of ischemic stroke	enoxaparin	2	B01AB05	7	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	enoxaparin	1	B01AB05	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	enoxaparin	5	B01AB05	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	enoxaparin	3	B01AB05	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	enoxaparin	4	B01AB05	7	1
35269	"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	danaparoid	7	B01AB09	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	tinzaparin	1	B01AB10	7	1
10585	Acute coronary syndromes. A national clinical guideline	clopidogrel	3	B01AC04	7	1
14328	Stroke. Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA)	clopidogrel	1	B01AC04	7	1
16393	Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction	clopidogrel	15	B01AC04	7	1
16394	Management of diabetes. A national clinical guideline	clopidogrel	2	B01AC04	7	1
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	clopidogrel	1	B01AC04	7	1
23909	Evaluation and therapy for heart failure in the setting of ischemic heart disease: HFSA 2010 comprehensive heart failure practice guideline	clopidogrel	1	B01AC04	7	1
24172	Secondary prevention. In: Clinical guidelines for stroke management 2010	clopidogrel	3	B01AC04	7	1
24713	Coronary heart disease	clopidogrel	6	B01AC04	7	1
33192	Acute coronary syndrome and myocardial infarction	clopidogrel	8	B01AC04	7	1
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	clopidogrel	1	B01AC04	7	1
34087	Prevention of stroke. In: Canadian best practice recommendations for stroke care	clopidogrel	4	B01AC04	7	1
34113	Cardiometabolic risk management guidelines in primary care	clopidogrel	1	B01AC04	7	1
34278	Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events	clopidogrel	6	B01AC04	7	1
34978	Guidelines on oral anticoagulation with warfarin - fourth edition	clopidogrel	4	B01AC04	7	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	clopidogrel	6	B01AC04	7	1
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	clopidogrel	22	B01AC04	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	clopidogrel	8	B01AC04	7	1
35270	"Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	clopidogrel	13	B01AC04	7	1
35271	"Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	clopidogrel	1	B01AC04	7	1
35272	"Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	clopidogrel	6	B01AC04	7	1
35273	"Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	clopidogrel	16	B01AC04	7	1
38254	Diagnosis and initial treatment of ischemic stroke	clopidogrel	2	B01AC04	7	1
38367	Antithrombotics: indications and management. A national clinical guideline	clopidogrel	1	B01AC04	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	clopidogrel	19	B01AC04	7	1
39354	European guidelines on cardiovascular disease prevention in clinical practice (version 2012)	clopidogrel	4	B01AC04	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	clopidogrel	9	B01AC04	7	1
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	clopidogrel	2	B01AC04	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	clopidogrel	15	B01AC04	7	1
46241	Stable coronary artery disease	clopidogrel	4	B01AC04	7	1
47019	Myocardial infarction with ST-segment elevation. The acute management of myocardial infarction with ST-segment elevation	clopidogrel	1	B01AC04	7	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	clopidogrel	8	B01AC04	7	1
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	clopidogrel	1	B01AC04	7	1
47873	Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation. Report of the Guideline Development Subcommittee of the American Academy of Neurology	clopidogrel	1	B01AC04	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	clopidogrel	7	B01AC04	7	1
48267	2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	clopidogrel	1	B01AC04	7	1
49123	Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome	clopidogrel	3	B01AC04	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	ticlopidine	1	B01AC05	7	1
14328	Stroke. Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA)	dipyridamole	1	B01AC07	7	1
16392	Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin	dipyridamole	2	B01AC07	7	1
24172	Secondary prevention. In: Clinical guidelines for stroke management 2010	dipyridamole	2	B01AC07	7	1
34087	Prevention of stroke. In: Canadian best practice recommendations for stroke care	dipyridamole	1	B01AC07	7	1
34278	Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events	dipyridamole	3	B01AC07	7	1
35272	"Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	dipyridamole	2	B01AC07	7	1
38367	Antithrombotics: indications and management. A national clinical guideline	dipyridamole	2	B01AC07	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	dipyridamole	1	B01AC07	7	1
39354	European guidelines on cardiovascular disease prevention in clinical practice (version 2012)	dipyridamole	2	B01AC07	7	1
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	dipyridamole	1	B01AC07	7	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	dipyridamole	1	B01AC07	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	dipyridamole	1	B01AC07	7	1
16393	Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction	abciximab	1	B01AC13	7	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	abciximab	2	B01AC13	7	1
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	abciximab	7	B01AC13	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	abciximab	5	B01AC13	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	abciximab	3	B01AC13	7	1
16393	Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction	eptifibatide	2	B01AC16	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	eptifibatide	1	B01AC16	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	eptifibatide	2	B01AC16	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	eptifibatide	2	B01AC16	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	eptifibatide	2	B01AC16	7	1
16393	Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction	tirofiban	2	B01AC17	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	tirofiban	1	B01AC17	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	tirofiban	2	B01AC17	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	tirofiban	2	B01AC17	7	1
35272	"Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	triflusal	1	B01AC18	7	1
47873	Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation. Report of the Guideline Development Subcommittee of the American Academy of Neurology	triflusal	3	B01AC18	7	1
16393	Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction	prasugrel	2	B01AC22	7	1
33192	Acute coronary syndrome and myocardial infarction	prasugrel	2	B01AC22	7	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	prasugrel	4	B01AC22	7	1
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	prasugrel	7	B01AC22	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	prasugrel	3	B01AC22	7	1
35273	"Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	prasugrel	2	B01AC22	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	prasugrel	10	B01AC22	7	1
39354	European guidelines on cardiovascular disease prevention in clinical practice (version 2012)	prasugrel	2	B01AC22	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	prasugrel	5	B01AC22	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	prasugrel	8	B01AC22	7	1
47019	Myocardial infarction with ST-segment elevation. The acute management of myocardial infarction with ST-segment elevation	prasugrel	1	B01AC22	7	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	prasugrel	2	B01AC22	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	prasugrel	1	B01AC22	7	1
48404	Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes (review of technology appraisal guidance 182)	prasugrel	1	B01AC22	7	1
35272	"Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	cilostazol	2	B01AC23	7	1
35273	"Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	cilostazol	3	B01AC23	7	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	ticagrelor	5	B01AC24	7	1
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	ticagrelor	6	B01AC24	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	ticagrelor	2	B01AC24	7	1
35273	"Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	ticagrelor	4	B01AC24	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	ticagrelor	7	B01AC24	7	1
39354	European guidelines on cardiovascular disease prevention in clinical practice (version 2012)	ticagrelor	2	B01AC24	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	ticagrelor	6	B01AC24	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	ticagrelor	6	B01AC24	7	1
47019	Myocardial infarction with ST-segment elevation. The acute management of myocardial infarction with ST-segment elevation	ticagrelor	3	B01AC24	7	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	ticagrelor	4	B01AC24	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	ticagrelor	1	B01AC24	7	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	streptokinase	1	B01AD01	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	streptokinase	2	B01AD01	7	1
38367	Antithrombotics: indications and management. A national clinical guideline	streptokinase	1	B01AD01	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	streptokinase	4	B01AD01	7	1
14328	Stroke. Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA)	alteplase	4	B01AD02	7	1
33192	Acute coronary syndrome and myocardial infarction	alteplase	1	B01AD02	7	1
38443	Alteplase for treating acute ischaemic stroke (review of technology appraisal guidance 122)	alteplase	5	B01AD02	7	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	urokinase	1	B01AD04	7	0
33192	Acute coronary syndrome and myocardial infarction	reteplase	2	B01AD07	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	reteplase	1	B01AD07	7	1
33192	Acute coronary syndrome and myocardial infarction	tenecteplase	2	B01AD11	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	tenecteplase	1	B01AD11	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	tenecteplase	1	B01AD11	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	protein c	1	B01AD12	7	0
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	protein c	3	B01AD12	7	0
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	direct thrombin inhibitors	1	B01AE	5	1
38254	Diagnosis and initial treatment of ischemic stroke	direct thrombin inhibitors	1	B01AE	5	1
48267	2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	direct thrombin inhibitors	1	B01AE	5	1
35269	"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	lepirudin	5	B01AE02	7	1
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	argatroban	2	B01AE03	7	1
35269	"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	argatroban	8	B01AE03	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	argatroban	1	B01AE03	7	1
16393	Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction	bivalirudin	2	B01AE06	7	1
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	bivalirudin	5	B01AE06	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	bivalirudin	6	B01AE06	7	1
35269	"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	bivalirudin	2	B01AE06	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	bivalirudin	5	B01AE06	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	bivalirudin	4	B01AE06	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	bivalirudin	2	B01AE06	7	1
47019	Myocardial infarction with ST-segment elevation. The acute management of myocardial infarction with ST-segment elevation	bivalirudin	2	B01AE06	7	1
36887	Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation	dabigatran etexilate	4	B01AE07	7	1
38367	Antithrombotics: indications and management. A national clinical guideline	dabigatran etexilate	2	B01AE07	7	1
43837	Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation	dabigatran etexilate	1	B01AE07	7	1
48333	Atrial fibrillation: the management of atrial fibrillation	dabigatran etexilate	9	B01AE07	7	1
38367	Antithrombotics: indications and management. A national clinical guideline	rivaroxaban	2	B01AF01	7	1
43837	Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation	rivaroxaban	1	B01AF01	7	1
45138	Recommendations for antithrombotic agents for the prevention of stroke and systemic embolism in patients with atrial fibrillation	rivaroxaban	2	B01AF01	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	rivaroxaban	1	B01AF01	7	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	rivaroxaban	2	B01AF01	7	1
47873	Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation. Report of the Guideline Development Subcommittee of the American Academy of Neurology	rivaroxaban	5	B01AF01	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	rivaroxaban	5	B01AF01	7	1
48333	Atrial fibrillation: the management of atrial fibrillation	rivaroxaban	9	B01AF01	7	1
49123	Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome	rivaroxaban	4	B01AF01	7	1
38367	Antithrombotics: indications and management. A national clinical guideline	apixaban	3	B01AF02	7	1
43837	Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation	apixaban	4	B01AF02	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	apixaban	1	B01AF02	7	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	apixaban	2	B01AF02	7	1
47873	Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation. Report of the Guideline Development Subcommittee of the American Academy of Neurology	apixaban	7	B01AF02	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	apixaban	6	B01AF02	7	1
48333	Atrial fibrillation: the management of atrial fibrillation	apixaban	8	B01AF02	7	1
10585	Acute coronary syndromes. A national clinical guideline	fondaparinux	2	B01AX05	7	1
16393	Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction	fondaparinux	6	B01AX05	7	1
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	fondaparinux	1	B01AX05	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	fondaparinux	19	B01AX05	7	1
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	fondaparinux	2	B01AX05	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	fondaparinux	6	B01AX05	7	1
35262	"Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	fondaparinux	3	B01AX05	7	1
35269	"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	fondaparinux	2	B01AX05	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	fondaparinux	11	B01AX05	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	fondaparinux	7	B01AX05	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	fondaparinux	3	B01AX05	7	1
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	aminocaproic acid	1	B02AA01	7	1
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	tranexamic acid	1	B02AA02	7	
33192	Acute coronary syndrome and myocardial infarction	phytomenadione	1	B02BA01	7	
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	thrombin	1	B02BC06	7	0
35269	"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	thrombin	1	B02BC06	7	0
38254	Diagnosis and initial treatment of ischemic stroke	thrombin	1	B02BC06	7	0
39222	2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management	thrombin	1	B02BC06	7	0
39247	"2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design"	thrombin	2	B02BC06	7	0
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	thrombin	1	B02BC06	7	0
48267	2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	thrombin	1	B02BC06	7	0
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	collagen	1	B02BC07	7	0
37827	Osteoporosis in men: an Endocrine Society clinical practice guideline	collagen	2	B02BC07	7	0
39382	Taiwan osteoporosis practice guidelines	collagen	2	B02BC07	7	0
23924	Chronic kidney disease evidence-based nutrition practice guideline	vitamin b12 and folic acid	2	B03B	4	1
14329	Identification and management of familial hypercholesterolaemia	folic acid	1	B03BB01	7	1
23924	Chronic kidney disease evidence-based nutrition practice guideline	folic acid	2	B03BB01	7	1
24712	Treatment of dyslipidaemias	folic acid	1	B03BB01	7	1
24713	Coronary heart disease	folic acid	1	B03BB01	7	1
34277	"Dietary guidelines for Americans, 2010"	folic acid	2	B03BB01	7	1
34281	Anaemia management in people with chronic kidney disease	folic acid	1	B03BB01	7	1
34444	Clinical practice guideline for dementia. Part I: diagnosis &amp;amp; evaluation	folic acid	1	B03BB01	7	1
38245	KDIGO clinical practice guideline for anemia in chronic kidney disease	folic acid	1	B03BB01	7	1
43766	"Preventive activities prior to pregnancy. In: Guidelines for preventive activities in general practice, 8th edition"	folic acid	3	B03BB01	7	1
43916	Age-related changes in health. In: Evidence-based geriatric nursing protocols for best practice	folic acid	1	B03BB01	7	1
43926	"Heart failure: early recognition, and treatment of the patient at risk for hospital readmission. In: Evidence-based geriatric nursing protocols for best practice"	folic acid	1	B03BB01	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	folic acid	1	B03BB01	7	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	folic acid	1	B03BB01	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	folic acid	2	B03BB01	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	folic acid	1	B03BB01	7	1
47898	Diabetes and pregnancy: an Endocrine Society clinical practice guideline	folic acid	5	B03BB01	7	1
34281	Anaemia management in people with chronic kidney disease	erythropoietin	3	B03XA01	7	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	erythropoietin	1	B03XA01	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	erythropoietin	1	B03XA01	7	1
45378	Guideline for the laboratory diagnosis of functional iron deficiency	erythropoietin	2	B03XA01	7	1
38245	KDIGO clinical practice guideline for anemia in chronic kidney disease	peginesatide	1	B03XA04	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	albumin	2	B05AA01	7	1
16392	Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin	albumin	1	B05AA01	7	1
16394	Management of diabetes. A national clinical guideline	albumin	1	B05AA01	7	1
23848	Management of patients with stroke: identification and management of dysphagia. A national clinical guideline	albumin	1	B05AA01	7	1
23900	Evaluation of patients for ventricular dysfunction and heart failure: HFSA 2010 comprehensive heart failure practice guideline	albumin	1	B05AA01	7	1
24176	"Guideline recommendations and their rationales for the treatment of adult patients. In: Shared decision-making in the appropriate initiation of and withdrawal from dialysis, 2nd edition"	albumin	2	B05AA01	7	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	albumin	4	B05AA01	7	1
25310	2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	albumin	1	B05AA01	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	albumin	1	B05AA01	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	albumin	1	B05AA01	7	1
34113	Cardiometabolic risk management guidelines in primary care	albumin	3	B05AA01	7	1
34166	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus	albumin	5	B05AA01	7	1
34824	Hypertension. Clinical management of primary hypertension in adults	albumin	1	B05AA01	7	1
36628	Clinical practice guideline for type 2 diabetes	albumin	1	B05AA01	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	albumin	1	B05AA01	7	1
38365	Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement&lt;/div&gt;	albumin	1	B05AA01	7	1
38460	Basic guidelines for diabetes care	albumin	1	B05AA01	7	1
38898	Diabetes care	albumin	1	B05AA01	7	1
39393	Kidney disease in HIV-infected patients	albumin	1	B05AA01	7	1
39430	KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease	albumin	14	B05AA01	7	1
43788	KDOQI clinical practice guideline for diabetes and CKD: 2012 update&lt;/div&gt;	albumin	1	B05AA01	7	1
43854	"Prevention of vascular and metabolic disease. In: Guidelines for preventive activities in general practice, 8th edition"	albumin	7	B05AA01	7	1
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	albumin	11	B05AA01	7	1
46648	Diagnosis and management of adults with chronic kidney disease	albumin	1	B05AA01	7	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	albumin	2	B05AA01	7	1
46910	2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult	albumin	1	B05AA01	7	1
47030	Heart failure in adults	albumin	1	B05AA01	7	1
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	albumin	1	B05AA01	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	albumin	7	B05AA01	7	1
47898	Diabetes and pregnancy: an Endocrine Society clinical practice guideline	albumin	1	B05AA01	7	1
48117	Guidelines for the management of absolute cardiovascular disease risk	albumin	1	B05AA01	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	albumin	1	B05AA01	7	1
48544	Diagnosis and management of type 2 diabetes mellitus in adults	albumin	3	B05AA01	7	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	albumin	1	B05AA01	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	dextran	1	B05AA05	7	1
38245	KDIGO clinical practice guideline for anemia in chronic kidney disease	dextran	1	B05AA05	7	1
47568	World Gastroenterology Organisation global guideline: obesity	amino acids	3	B05BA01	7	0
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	amino acids	1	B05BA01	7	0
16394	Management of diabetes. A national clinical guideline	carbohydrates	1	B05BA03	7	0
24712	Treatment of dyslipidaemias	carbohydrates	2	B05BA03	7	0
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	carbohydrates	1	B05BA03	7	0
36628	Clinical practice guideline for type 2 diabetes	carbohydrates	1	B05BA03	7	0
43916	Age-related changes in health. In: Evidence-based geriatric nursing protocols for best practice	carbohydrates	1	B05BA03	7	0
47568	World Gastroenterology Organisation global guideline: obesity	carbohydrates	2	B05BA03	7	0
47865	Clinical practice guideline for diabetes mellitus type 1	carbohydrates	11	B05BA03	7	0
48544	Diagnosis and management of type 2 diabetes mellitus in adults	carbohydrates	3	B05BA03	7	0
49117	Maintaining a healthy weight and preventing excess weight gain among adults and children	carbohydrates	1	B05BA03	7	0
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	electrolytes	1	B05BB01	7	
23900	Evaluation of patients for ventricular dysfunction and heart failure: HFSA 2010 comprehensive heart failure practice guideline	electrolytes	3	B05BB01	7	
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	electrolytes	1	B05BB01	7	
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	electrolytes	3	B05BB01	7	
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	electrolytes	4	B05BB01	7	
24170	Early assessment and diagnosis. In: Clinical guidelines for stroke management 2010	electrolytes	2	B05BB01	7	
32492	Heart failure in the long-term care setting	electrolytes	2	B05BB01	7	
33192	Acute coronary syndrome and myocardial infarction	electrolytes	1	B05BB01	7	
34444	Clinical practice guideline for dementia. Part I: diagnosis &amp;amp; evaluation	electrolytes	2	B05BB01	7	
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	electrolytes	2	B05BB01	7	
34824	Hypertension. Clinical management of primary hypertension in adults	electrolytes	1	B05BB01	7	
38254	Diagnosis and initial treatment of ischemic stroke	electrolytes	5	B05BB01	7	
38255	Diagnosis and management of asthma	electrolytes	1	B05BB01	7	
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	electrolytes	1	B05BB01	7	
39244	"Rheumatoid arthritis: diagnosis, management and monitoring"	electrolytes	1	B05BB01	7	
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	electrolytes	1	B05BB01	7	
39404	Critical illness evidence-based nutrition practice guideline	electrolytes	2	B05BB01	7	
43926	"Heart failure: early recognition, and treatment of the patient at risk for hospital readmission. In: Evidence-based geriatric nursing protocols for best practice"	electrolytes	1	B05BB01	7	
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	electrolytes	1	B05BB01	7	
46648	Diagnosis and management of adults with chronic kidney disease	electrolytes	1	B05BB01	7	
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	electrolytes	1	B05BB01	7	
47030	Heart failure in adults	electrolytes	2	B05BB01	7	
47108	Adults with systolic heart failure	electrolytes	2	B05BB01	7	
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	electrolytes	4	B05BB01	7	
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	electrolytes	1	B05BB01	7	
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	electrolytes	1	B05BB01	7	
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	electrolytes	1	B05BB01	7	
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	electrolytes	1	B05BB01	7	
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	electrolytes	3	B05BB01	7	
48752	Acute heart failure: diagnosing and managing acute heart failure in adults	electrolytes	1	B05BB01	7	
48951	VA/DoD clinical practice guideline for the management of chronic kidney disease in primary care	sodium bicarbonate	1	B05CB04	7	1
10585	Acute coronary syndromes. A national clinical guideline	glucose	1	B05CX01	7	0
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	glucose	21	B05CX01	7	0
14328	Stroke. Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA)	glucose	2	B05CX01	7	0
16393	Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction	glucose	1	B05CX01	7	0
16394	Management of diabetes. A national clinical guideline	glucose	13	B05CX01	7	0
23848	Management of patients with stroke: identification and management of dysphagia. A national clinical guideline	glucose	1	B05CX01	7	0
23849	"Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline"	glucose	1	B05CX01	7	0
23900	Evaluation of patients for ventricular dysfunction and heart failure: HFSA 2010 comprehensive heart failure practice guideline	glucose	1	B05CX01	7	0
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	glucose	1	B05CX01	7	0
24170	Early assessment and diagnosis. In: Clinical guidelines for stroke management 2010	glucose	2	B05CX01	7	0
24171	Acute medical and surgical management. In: Clinical guidelines for stroke management 2010	glucose	2	B05CX01	7	0
24172	Secondary prevention. In: Clinical guidelines for stroke management 2010	glucose	1	B05CX01	7	0
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	glucose	31	B05CX01	7	0
24712	Treatment of dyslipidaemias	glucose	1	B05CX01	7	0
24713	Coronary heart disease	glucose	7	B05CX01	7	0
25311	Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society clinical practice guideline	glucose	2	B05CX01	7	0
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	glucose	5	B05CX01	7	0
25679	Liraglutide for the treatment of type 2 diabetes mellitus	glucose	1	B05CX01	7	0
32410	Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement	glucose	4	B05CX01	7	0
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	glucose	1	B05CX01	7	0
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	glucose	12	B05CX01	7	0
34087	Prevention of stroke. In: Canadian best practice recommendations for stroke care	glucose	9	B05CX01	7	0
34113	Cardiometabolic risk management guidelines in primary care	glucose	12	B05CX01	7	0
34166	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus	glucose	29	B05CX01	7	0
34168	Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians	glucose	15	B05CX01	7	0
34444	Clinical practice guideline for dementia. Part I: diagnosis &amp;amp; evaluation	glucose	3	B05CX01	7	0
34755	(1) Stroke assessment across the continuum of care. (2) Stroke assessment across the continuum of care 2011 supplement	glucose	1	B05CX01	7	0
34758	Strategies to support self-management in chronic conditions: collaboration with clients	glucose	1	B05CX01	7	0
34824	Hypertension. Clinical management of primary hypertension in adults	glucose	1	B05CX01	7	0
34837	Hyperglycaemia in acute coronary syndromes. Management of hyperglycaemia in acute coronary syndromes	glucose	8	B05CX01	7	0
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	glucose	3	B05CX01	7	0
35239	Diabetes management at camps for children with diabetes	glucose	35	B05CX01	7	0
35254	Continuous glucose monitoring: an Endocrine Society clinical practice guideline	glucose	2	B05CX01	7	0
35255	Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline	glucose	6	B05CX01	7	0
35257	Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians	glucose	1	B05CX01	7	0
36628	Clinical practice guideline for type 2 diabetes	glucose	3	B05CX01	7	0
36825	Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\'s Multidisciplinary Consensus Conference	glucose	5	B05CX01	7	0
36888	Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes	glucose	1	B05CX01	7	0
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	glucose	1	B05CX01	7	0
37710	Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement	glucose	3	B05CX01	7	0
37915	ACR Appropriateness Criteria&amp;reg; suspected osteomyelitis of the foot in patients with diabetes mellitus	glucose	2	B05CX01	7	0
38254	Diagnosis and initial treatment of ischemic stroke	glucose	12	B05CX01	7	0
38432	Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline	glucose	1	B05CX01	7	0
38460	Basic guidelines for diabetes care	glucose	3	B05CX01	7	0
38470	EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia	glucose	1	B05CX01	7	0
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	glucose	2	B05CX01	7	0
38473	Recommendations on screening for type 2 diabetes in adults	glucose	4	B05CX01	7	0
38490	A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia	glucose	2	B05CX01	7	0
38618	Management of type 2 diabetes mellitus	glucose	4	B05CX01	7	0
38898	Diabetes care	glucose	17	B05CX01	7	0
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	glucose	5	B05CX01	7	0
39338	Screening for cardiovascular disease and risk factors	glucose	10	B05CX01	7	0
39354	European guidelines on cardiovascular disease prevention in clinical practice (version 2012)	glucose	2	B05CX01	7	0
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	glucose	2	B05CX01	7	0
39404	Critical illness evidence-based nutrition practice guideline	glucose	7	B05CX01	7	0
39539	Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents	glucose	2	B05CX01	7	0
43766	"Preventive activities prior to pregnancy. In: Guidelines for preventive activities in general practice, 8th edition"	glucose	1	B05CX01	7	0
43850	"Preventive activities in middle age. In: Guidelines for preventive activities in general practice, 8th edition"	glucose	2	B05CX01	7	0
43853	"Prevention of chronic disease. In: Guidelines for preventive activities in general practice, 8th edition"	glucose	1	B05CX01	7	0
43854	"Prevention of vascular and metabolic disease. In: Guidelines for preventive activities in general practice, 8th edition"	glucose	11	B05CX01	7	0
43906	EFNS task force: the use of neuroimaging in the diagnosis of dementia	glucose	1	B05CX01	7	0
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	glucose	1	B05CX01	7	0
45527	Diabetes management in the long term care setting	glucose	28	B05CX01	7	0
46239	Healthy lifestyles	glucose	1	B05CX01	7	0
46240	Prevention and management of obesity for adults	glucose	2	B05CX01	7	0
46241	Stable coronary artery disease	glucose	1	B05CX01	7	0
46654	Management of overweight and obesity in the adult	glucose	1	B05CX01	7	0
46655	Management of diabetes mellitus	glucose	2	B05CX01	7	0
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	glucose	1	B05CX01	7	0
46910	2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult	glucose	1	B05CX01	7	0
47027	Obesity prevention and management	glucose	1	B05CX01	7	0
47030	Heart failure in adults	glucose	5	B05CX01	7	0
47108	Adults with systolic heart failure	glucose	1	B05CX01	7	0
47151	Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation	glucose	1	B05CX01	7	0
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	glucose	1	B05CX01	7	0
47568	World Gastroenterology Organisation global guideline: obesity	glucose	3	B05CX01	7	0
47592	"Diabetes (type 1, 2, and gestational)"	glucose	19	B05CX01	7	0
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	glucose	15	B05CX01	7	0
47783	Lipid management in adults	glucose	5	B05CX01	7	0
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	glucose	1	B05CX01	7	0
47865	Clinical practice guideline for diabetes mellitus type 1	glucose	37	B05CX01	7	0
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	glucose	1	B05CX01	7	0
47898	Diabetes and pregnancy: an Endocrine Society clinical practice guideline	glucose	44	B05CX01	7	0
47915	Evidence-based clinical practice guideline: eye care of the patient with diabetes mellitus	glucose	3	B05CX01	7	0
48280	ACR Appropriateness Criteria&amp;reg; chest pain suggestive of acute coronary syndrome	glucose	1	B05CX01	7	0
48285	ACR Appropriateness Criteria&amp;reg; dementia and movement disorders	glucose	5	B05CX01	7	0
48337	2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	glucose	1	B05CX01	7	0
48339	2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society	glucose	3	B05CX01	7	0
48406	Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease	glucose	1	B05CX01	7	0
48461	VA/DoD clinical practice guideline for screening and management of overweight and obesity	glucose	2	B05CX01	7	0
48544	Diagnosis and management of type 2 diabetes mellitus in adults	glucose	30	B05CX01	7	0
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	glucose	5	B05CX01	7	0
48761	Adult weight management evidence-based nutrition practice guideline	glucose	4	B05CX01	7	0
48762	Prevention of type 2 diabetes evidence-based nutrition practice guideline	glucose	11	B05CX01	7	0
48872	"Obesity: identification, assessment and management of overweight and obesity in children, young people and adults"	glucose	2	B05CX01	7	0
48950	VA/DoD clinical practice guideline for the management of dyslipidemia for cardiovascular risk reduction	glucose	4	B05CX01	7	0
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	glucose	2	B05CX01	7	0
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	lysine	1	B05XB03	7	0
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	hyaluronidase	1	B06AA03	7	0
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	trypsin	1	B06AA07	7	0
10587	Management of chronic heart failure. A national clinical guideline	digoxin	1	C01AA05	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	digoxin	1	C01AA05	7	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	digoxin	1	C01AA05	7	1
23902	Nonpharmacologic management and health care maintenance of patients with chronic heart failure: HFSA 2010 comprehensive heart failure practice guideline	digoxin	1	C01AA05	7	1
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	digoxin	6	C01AA05	7	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	digoxin	8	C01AA05	7	1
24712	Treatment of dyslipidaemias	digoxin	1	C01AA05	7	1
32492	Heart failure in the long-term care setting	digoxin	3	C01AA05	7	1
33192	Acute coronary syndrome and myocardial infarction	digoxin	4	C01AA05	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	digoxin	1	C01AA05	7	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	digoxin	1	C01AA05	7	1
36906	Prevention of falls (acute care). Health care protocol	digoxin	1	C01AA05	7	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	digoxin	1	C01AA05	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	digoxin	3	C01AA05	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	digoxin	10	C01AA05	7	1
46241	Stable coronary artery disease	digoxin	2	C01AA05	7	1
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	digoxin	1	C01AA05	7	1
47030	Heart failure in adults	digoxin	15	C01AA05	7	1
47084	Heart failure - systolic dysfunction	digoxin	1	C01AA05	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	digoxin	2	C01AA05	7	1
48333	Atrial fibrillation: the management of atrial fibrillation	digoxin	3	C01AA05	7	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	digoxin	4	C01AA05	7	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	quinidine	1	C01BA01	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	procainamide	1	C01BA02	7	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	procainamide	1	C01BA02	7	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	disopyramide	5	C01BA03	7	1
47030	Heart failure in adults	disopyramide	2	C01BA03	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	lidocaine	1	C01BB01	7	1
33192	Acute coronary syndrome and myocardial infarction	lidocaine	2	C01BB01	7	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	lidocaine	2	C01BB01	7	1
47806	Medical management of adults with osteoarthritis	lidocaine	1	C01BB01	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	mexiletine	3	C01BB02	7	1
48333	Atrial fibrillation: the management of atrial fibrillation	propafenone	1	C01BC03	7	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	propafenone	1	C01BC03	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	flecainide	1	C01BC04	7	1
48333	Atrial fibrillation: the management of atrial fibrillation	flecainide	2	C01BC04	7	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	flecainide	1	C01BC04	7	1
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	amiodarone	7	C01BD01	7	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	amiodarone	4	C01BD01	7	1
33192	Acute coronary syndrome and myocardial infarction	amiodarone	6	C01BD01	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	amiodarone	1	C01BD01	7	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	amiodarone	1	C01BD01	7	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	amiodarone	1	C01BD01	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	amiodarone	1	C01BD01	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	amiodarone	13	C01BD01	7	1
47030	Heart failure in adults	amiodarone	2	C01BD01	7	1
48333	Atrial fibrillation: the management of atrial fibrillation	amiodarone	7	C01BD01	7	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	amiodarone	7	C01BD01	7	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	dofetilide	1	C01BD04	7	1
47030	Heart failure in adults	dofetilide	1	C01BD04	7	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	dofetilide	2	C01BD04	7	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	ibutilide	1	C01BD05	7	1
24113	Dronedarone for the treatment of non-permanent atrial fibrillation	dronedarone	3	C01BD07	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	dronedarone	1	C01BD07	7	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	dronedarone	1	C01BD07	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	dronedarone	3	C01BD07	7	1
48333	Atrial fibrillation: the management of atrial fibrillation	dronedarone	4	C01BD07	7	1
33192	Acute coronary syndrome and myocardial infarction	isoprenaline	2	C01CA02	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	norepinephrine	1	C01CA03	7	1
32668	Depression in the long term care setting	norepinephrine	3	C01CA03	7	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	norepinephrine	1	C01CA03	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	norepinephrine	1	C01CA03	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	norepinephrine	1	C01CA03	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	norepinephrine	1	C01CA03	7	1
39432	Diagnosis and treatment of depression in adults: 2012 clinical practice guideline	norepinephrine	2	C01CA03	7	1
47315	Adult depression in primary care	norepinephrine	2	C01CA03	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	dopamine	1	C01CA04	7	1
32493	Parkinson\'s disease in the long-term care setting	dopamine	4	C01CA04	7	1
32668	Depression in the long term care setting	dopamine	1	C01CA04	7	1
34900	Late (complicated) Parkinson\'s disease	dopamine	11	C01CA04	7	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	dopamine	1	C01CA04	7	1
38470	EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia	dopamine	1	C01CA04	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	dopamine	1	C01CA04	7	1
39432	Diagnosis and treatment of depression in adults: 2012 clinical practice guideline	dopamine	1	C01CA04	7	1
47030	Heart failure in adults	dopamine	1	C01CA04	7	1
47315	Adult depression in primary care	dopamine	1	C01CA04	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	dopamine	1	C01CA04	7	1
48285	ACR Appropriateness Criteria&amp;reg; dementia and movement disorders	dopamine	2	C01CA04	7	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	phenylephrine	1	C01CA06	7	1
16392	Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin	dobutamine	2	C01CA07	7	1
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	dobutamine	4	C01CA07	7	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	dobutamine	1	C01CA07	7	1
33192	Acute coronary syndrome and myocardial infarction	dobutamine	1	C01CA07	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	dobutamine	1	C01CA07	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	dobutamine	2	C01CA07	7	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	dobutamine	1	C01CA07	7	1
36825	Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\'s Multidisciplinary Consensus Conference	dobutamine	1	C01CA07	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	dobutamine	1	C01CA07	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	dobutamine	1	C01CA07	7	1
47030	Heart failure in adults	dobutamine	1	C01CA07	7	1
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	dobutamine	1	C01CA07	7	1
48267	2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	dobutamine	3	C01CA07	7	1
48280	ACR Appropriateness Criteria&amp;reg; chest pain suggestive of acute coronary syndrome	dobutamine	1	C01CA07	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	dopexamine	1	C01CA14	7	1
34900	Late (complicated) Parkinson\'s disease	midodrine	1	C01CA17	7	1
23902	Nonpharmacologic management and health care maintenance of patients with chronic heart failure: HFSA 2010 comprehensive heart failure practice guideline	ephedrine	1	C01CA26	7	1
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	milrinone	4	C01CE02	7	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	milrinone	1	C01CE02	7	1
47030	Heart failure in adults	milrinone	1	C01CE02	7	1
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	milrinone	1	C01CE02	7	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	enoximone	1	C01CE03	7	
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	xamoterol	3	C01CX07	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	levosimendan	1	C01CX08	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	levosimendan	1	C01CX08	7	1
10584	Management of stable angina. A national clinical guideline	glyceryl trinitrate	1	C01DA02	7	1
16392	Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin	glyceryl trinitrate	2	C01DA02	7	1
24713	Coronary heart disease	glyceryl trinitrate	3	C01DA02	7	1
33192	Acute coronary syndrome and myocardial infarction	glyceryl trinitrate	1	C01DA02	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	glyceryl trinitrate	1	C01DA02	7	1
10587	Management of chronic heart failure. A national clinical guideline	isosorbide dinitrate	2	C01DA08	7	1
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	isosorbide dinitrate	4	C01DA08	7	1
23910	Managing patients with hypertension and heart failure: HFSA 2010 comprehensive heart failure practice guideline	isosorbide dinitrate	1	C01DA08	7	1
23911	Management of heart failure in special populations: HFSA 2010 comprehensive heart failure practice guideline	isosorbide dinitrate	2	C01DA08	7	1
32492	Heart failure in the long-term care setting	isosorbide dinitrate	2	C01DA08	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	isosorbide dinitrate	2	C01DA08	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	isosorbide dinitrate	1	C01DA08	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	isosorbide dinitrate	1	C01DA08	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	isosorbide dinitrate	1	C01DA08	7	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	isosorbide dinitrate	1	C01DA08	7	1
47030	Heart failure in adults	isosorbide dinitrate	2	C01DA08	7	1
47084	Heart failure - systolic dysfunction	isosorbide dinitrate	1	C01DA08	7	1
47108	Adults with systolic heart failure	isosorbide dinitrate	1	C01DA08	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	isosorbide dinitrate	2	C01DA08	7	1
10584	Management of stable angina. A national clinical guideline	nicorandil	1	C01DX16	7	1
34825	Management of stable angina	nicorandil	3	C01DX16	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	nicorandil	4	C01DX16	7	1
43946	Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines	nicorandil	3	C01DX16	7	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	nicorandil	2	C01DX16	7	1
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	nesiritide	3	C01DX19	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	nesiritide	1	C01DX19	7	1
47030	Heart failure in adults	nesiritide	1	C01DX19	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	nesiritide	1	C01DX19	7	1
34900	Late (complicated) Parkinson\'s disease	alprostadil	1	C01EA01	7	1
36628	Clinical practice guideline for type 2 diabetes	alprostadil	1	C01EA01	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	alprostadil	1	C01EA01	7	1
16392	Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin	adenosine	2	C01EB10	7	1
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	adenosine	1	C01EB10	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	adenosine	1	C01EB10	7	1
43946	Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines	trimetazidine	2	C01EB15	7	1
36825	Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\'s Multidisciplinary Consensus Conference	ibuprofen	1	C01EB16	7	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	ibuprofen	2	C01EB16	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	ibuprofen	1	C01EB16	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	ibuprofen	2	C01EB16	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	ivabradine	1	C01EB17	7	1
34825	Management of stable angina	ivabradine	3	C01EB17	7	1
39220	Ivabradine for treating chronic heart failure	ivabradine	4	C01EB17	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	ivabradine	6	C01EB17	7	1
43946	Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines	ivabradine	5	C01EB17	7	1
34825	Management of stable angina	ranolazine	2	C01EB18	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	ranolazine	3	C01EB18	7	1
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	ranolazine	2	C01EB18	7	1
43946	Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines	ranolazine	4	C01EB18	7	1
46241	Stable coronary artery disease	ranolazine	4	C01EB18	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	antihypertensives	2	C02	3	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	antihypertensives	3	C02	3	1
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	antihypertensives	1	C02	3	1
43922	Depression in older adults. In: Evidence-based geriatric nursing protocols for best practice	antihypertensives	1	C02	3	1
46240	Prevention and management of obesity for adults	antihypertensives	1	C02	3	1
47289	Screening and management of hypercholesterolemia	antihypertensives	1	C02	3	1
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	reserpine	1	C02AA02	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	clonidine	1	C02AC01	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	clonidine	2	C02AC01	7	1
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	clonidine	1	C02AC01	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	clonidine	1	C02AC01	7	1
38254	Diagnosis and initial treatment of ischemic stroke	clonidine	1	C02AC01	7	1
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	clonidine	1	C02AC01	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	moxonidine	1	C02AC05	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	moxonidine	1	C02AC05	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	prazosin	1	C02CA01	7	1
10587	Management of chronic heart failure. A national clinical guideline	hydralazine	2	C02DB02	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	hydralazine	1	C02DB02	7	1
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	hydralazine	8	C02DB02	7	1
23910	Managing patients with hypertension and heart failure: HFSA 2010 comprehensive heart failure practice guideline	hydralazine	1	C02DB02	7	1
23911	Management of heart failure in special populations: HFSA 2010 comprehensive heart failure practice guideline	hydralazine	2	C02DB02	7	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	hydralazine	3	C02DB02	7	1
32492	Heart failure in the long-term care setting	hydralazine	2	C02DB02	7	1
34113	Cardiometabolic risk management guidelines in primary care	hydralazine	1	C02DB02	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	hydralazine	1	C02DB02	7	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	hydralazine	2	C02DB02	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	hydralazine	2	C02DB02	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	hydralazine	2	C02DB02	7	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	hydralazine	2	C02DB02	7	1
47030	Heart failure in adults	hydralazine	10	C02DB02	7	1
47084	Heart failure - systolic dysfunction	hydralazine	1	C02DB02	7	1
47108	Adults with systolic heart failure	hydralazine	1	C02DB02	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	hydralazine	3	C02DB02	7	1
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	hydralazine	1	C02DB02	7	1
34113	Cardiometabolic risk management guidelines in primary care	minoxidil	1	C02DC01	7	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	minoxidil	1	C02DC01	7	1
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	minoxidil	1	C02DC01	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	nitroprusside	1	C02DD01	7	1
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	nitroprusside	4	C02DD01	7	1
34166	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus	nitroprusside	1	C02DD01	7	1
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	nitroprusside	1	C02DD01	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	nitroprusside	2	C02DD01	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	nitroprusside	3	C02DD01	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	nitroprusside	1	C02DD01	7	1
48752	Acute heart failure: diagnosing and managing acute heart failure in adults	nitroprusside	1	C02DD01	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	diuretics	1	C03	3	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	diuretics	10	C03	3	1
23900	Evaluation of patients for ventricular dysfunction and heart failure: HFSA 2010 comprehensive heart failure practice guideline	diuretics	1	C03	3	1
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	diuretics	12	C03	3	1
23904	"Disease management, advance directives, and end-of-life care in heart failure: HFSA 2010 comprehensive heart failure practice guideline"	diuretics	1	C03	3	1
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	diuretics	9	C03	3	1
23911	Management of heart failure in special populations: HFSA 2010 comprehensive heart failure practice guideline	diuretics	1	C03	3	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	diuretics	4	C03	3	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	diuretics	4	C03	3	1
24712	Treatment of dyslipidaemias	diuretics	1	C03	3	1
32410	Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement	diuretics	1	C03	3	1
32491	COPD management in the long-term care setting	diuretics	1	C03	3	1
32492	Heart failure in the long-term care setting	diuretics	3	C03	3	1
33192	Acute coronary syndrome and myocardial infarction	diuretics	1	C03	3	1
34113	Cardiometabolic risk management guidelines in primary care	diuretics	12	C03	3	1
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	diuretics	1	C03	3	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	diuretics	3	C03	3	1
34900	Late (complicated) Parkinson\'s disease	diuretics	1	C03	3	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	diuretics	3	C03	3	1
36825	Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\'s Multidisciplinary Consensus Conference	diuretics	1	C03	3	1
36906	Prevention of falls (acute care). Health care protocol	diuretics	1	C03	3	1
37941	ACR Appropriateness Criteria&amp;reg; renovascular hypertension	diuretics	1	C03	3	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	diuretics	1	C03	3	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	diuretics	2	C03	3	1
39354	European guidelines on cardiovascular disease prevention in clinical practice (version 2012)	diuretics	2	C03	3	1
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	diuretics	1	C03	3	1
46240	Prevention and management of obesity for adults	diuretics	1	C03	3	1
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	diuretics	1	C03	3	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	diuretics	7	C03	3	1
47030	Heart failure in adults	diuretics	21	C03	3	1
47084	Heart failure - systolic dysfunction	diuretics	2	C03	3	1
47108	Adults with systolic heart failure	diuretics	1	C03	3	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	diuretics	9	C03	3	1
47543	Diagnosis and treatment of osteoporosis	diuretics	1	C03	3	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	diuretics	1	C03	3	1
48267	2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	diuretics	2	C03	3	1
48544	Diagnosis and management of type 2 diabetes mellitus in adults	diuretics	2	C03	3	1
48752	Acute heart failure: diagnosing and managing acute heart failure in adults	diuretics	2	C03	3	1
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	diuretics	4	C03	3	1
34824	Hypertension. Clinical management of primary hypertension in adults	bendroflumethiazide	3	C03AA01	7	1
34824	Hypertension. Clinical management of primary hypertension in adults	hydrochlorothiazide	3	C03AA03	7	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	hydrochlorothiazide	1	C03AA03	7	1
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	hydrochlorothiazide	6	C03AA03	7	1
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	chlorothiazide	1	C03AA04	7	1
34824	Hypertension. Clinical management of primary hypertension in adults	chlortalidone	1	C03BA04	7	1
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	metolazone	3	C03BA08	7	1
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	metolazone	1	C03BA08	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	indapamide	2	C03BA11	7	1
34824	Hypertension. Clinical management of primary hypertension in adults	indapamide	1	C03BA11	7	1
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	indapamide	3	C03BA11	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	furosemide	1	C03CA01	7	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	furosemide	1	C03CA01	7	1
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	furosemide	1	C03CA01	7	1
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	furosemide	1	C03CA01	7	1
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	potassium-sparing diuretics	1	C03D	4	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	potassium-sparing diuretics	1	C03D	4	1
23900	Evaluation of patients for ventricular dysfunction and heart failure: HFSA 2010 comprehensive heart failure practice guideline	aldosterone antagonists	1	C03DA	5	1
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	aldosterone antagonists	2	C03DA	5	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	aldosterone antagonists	3	C03DA	5	1
32492	Heart failure in the long-term care setting	aldosterone antagonists	1	C03DA	5	1
39220	Ivabradine for treating chronic heart failure	aldosterone antagonists	2	C03DA	5	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	aldosterone antagonists	1	C03DA	5	1
47030	Heart failure in adults	aldosterone antagonists	5	C03DA	5	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	aldosterone antagonists	1	C03DA	5	1
48267	2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	aldosterone antagonists	1	C03DA	5	1
48544	Diagnosis and management of type 2 diabetes mellitus in adults	aldosterone antagonists	1	C03DA	5	1
48752	Acute heart failure: diagnosing and managing acute heart failure in adults	aldosterone antagonists	1	C03DA	5	1
10587	Management of chronic heart failure. A national clinical guideline	spironolactone	1	C03DA01	7	1
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	spironolactone	1	C03DA01	7	1
32492	Heart failure in the long-term care setting	spironolactone	1	C03DA01	7	1
34113	Cardiometabolic risk management guidelines in primary care	spironolactone	1	C03DA01	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	spironolactone	1	C03DA01	7	1
34824	Hypertension. Clinical management of primary hypertension in adults	spironolactone	2	C03DA01	7	1
47030	Heart failure in adults	spironolactone	3	C03DA01	7	1
47108	Adults with systolic heart failure	spironolactone	1	C03DA01	7	1
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	spironolactone	1	C03DA01	7	1
10585	Acute coronary syndromes. A national clinical guideline	eplerenone	1	C03DA04	7	1
10587	Management of chronic heart failure. A national clinical guideline	eplerenone	1	C03DA04	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	eplerenone	1	C03DA04	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	eplerenone	1	C03DA04	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	eplerenone	2	C03DA04	7	1
47030	Heart failure in adults	eplerenone	3	C03DA04	7	1
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	eplerenone	1	C03DA04	7	1
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	amiloride	1	C03DB01	7	1
14329	Identification and management of familial hypercholesterolaemia	nicotinic acid	4	C04AC01	7	1
15711	Clinical practice guideline on the management of lipids as a cardiovascular risk factor	nicotinic acid	1	C04AC01	7	1
24712	Treatment of dyslipidaemias	nicotinic acid	5	C04AC01	7	1
43854	"Prevention of vascular and metabolic disease. In: Guidelines for preventive activities in general practice, 8th edition"	nicotinic acid	2	C04AC01	7	1
48117	Guidelines for the management of absolute cardiovascular disease risk	nicotinic acid	3	C04AC01	7	1
48406	Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease	nicotinic acid	3	C04AC01	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	pentoxifylline	2	C04AD03	7	1
38245	KDIGO clinical practice guideline for anemia in chronic kidney disease	pentoxifylline	1	C04AD03	7	1
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	pentoxifylline	1	C04AD03	7	1
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	nicergoline	1	C04AE02	7	1
38409	Lower limb peripheral arterial disease: diagnosis and management	naftidrofuryl	3	C04AX21	7	
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	tetracaine	1	C05AD02	7	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	procaine	1	C05AD05	7	1
23907	Evaluation and management of patients with heart failure and preserved left ventricular ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	diltiazem	1	C05AE03	7	1
23909	Evaluation and therapy for heart failure in the setting of ischemic heart disease: HFSA 2010 comprehensive heart failure practice guideline	diltiazem	1	C05AE03	7	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	diltiazem	1	C05AE03	7	1
24713	Coronary heart disease	diltiazem	1	C05AE03	7	1
34113	Cardiometabolic risk management guidelines in primary care	diltiazem	1	C05AE03	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	diltiazem	1	C05AE03	7	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	diltiazem	2	C05AE03	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	diltiazem	1	C05AE03	7	1
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	diltiazem	1	C05AE03	7	1
47030	Heart failure in adults	diltiazem	1	C05AE03	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	diltiazem	2	C05AE03	7	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	diltiazem	2	C05AE03	7	1
48333	Atrial fibrillation: the management of atrial fibrillation	diltiazem	1	C05AE03	7	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	diltiazem	3	C05AE03	7	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	phenol	1	C05BB05	7	
39432	Diagnosis and treatment of depression in adults: 2012 clinical practice guideline	pindolol	1	C07AA03	7	1
47315	Adult depression in primary care	pindolol	1	C07AA03	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	pindolol	1	C07AA03	7	1
34113	Cardiometabolic risk management guidelines in primary care	propranolol	1	C07AA05	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	propranolol	1	C07AA05	7	1
33192	Acute coronary syndrome and myocardial infarction	sotalol	3	C07AA07	7	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	sotalol	1	C07AA07	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	sotalol	1	C07AA07	7	1
48333	Atrial fibrillation: the management of atrial fibrillation	sotalol	3	C07AA07	7	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	sotalol	2	C07AA07	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	metoprolol	1	C07AB02	7	1
33192	Acute coronary syndrome and myocardial infarction	metoprolol	2	C07AB02	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	metoprolol	1	C07AB02	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	metoprolol	3	C07AB02	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	metoprolol	4	C07AB02	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	metoprolol	1	C07AB02	7	1
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	metoprolol	1	C07AB02	7	1
47030	Heart failure in adults	metoprolol	2	C07AB02	7	1
47108	Adults with systolic heart failure	metoprolol	1	C07AB02	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	metoprolol	2	C07AB02	7	1
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	metoprolol	1	C07AB02	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	atenolol	1	C07AB03	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	atenolol	2	C07AB03	7	1
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	atenolol	1	C07AB03	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	bisoprolol	1	C07AB07	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	bisoprolol	1	C07AB07	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	bisoprolol	4	C07AB07	7	1
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	bisoprolol	1	C07AB07	7	1
47030	Heart failure in adults	bisoprolol	1	C07AB07	7	1
47108	Adults with systolic heart failure	bisoprolol	1	C07AB07	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	bisoprolol	1	C07AB07	7	1
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	bisoprolol	1	C07AB07	7	1
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	esmolol	2	C07AB09	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	esmolol	3	C07AB09	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	nebivolol	1	C07AB12	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	labetalol	4	C07AG01	7	1
34113	Cardiometabolic risk management guidelines in primary care	labetalol	2	C07AG01	7	1
34438	Care of the patient undergoing intracranial pressure monitoring/external ventricular drainage or lumbar drainage	labetalol	1	C07AG01	7	1
38254	Diagnosis and initial treatment of ischemic stroke	labetalol	1	C07AG01	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	labetalol	2	C07AG01	7	1
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	labetalol	1	C07AG01	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	carvedilol	1	C07AG02	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	carvedilol	4	C07AG02	7	1
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	carvedilol	1	C07AG02	7	1
47030	Heart failure in adults	carvedilol	2	C07AG02	7	1
47108	Adults with systolic heart failure	carvedilol	1	C07AG02	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	carvedilol	3	C07AG02	7	1
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	carvedilol	1	C07AG02	7	1
10584	Management of stable angina. A national clinical guideline	calcium channel blockers	1	C08	3	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	calcium channel blockers	1	C08	3	1
23907	Evaluation and management of patients with heart failure and preserved left ventricular ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	calcium channel blockers	1	C08	3	1
23909	Evaluation and therapy for heart failure in the setting of ischemic heart disease: HFSA 2010 comprehensive heart failure practice guideline	calcium channel blockers	3	C08	3	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	calcium channel blockers	1	C08	3	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	calcium channel blockers	1	C08	3	1
34113	Cardiometabolic risk management guidelines in primary care	calcium channel blockers	1	C08	3	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	calcium channel blockers	1	C08	3	1
34825	Management of stable angina	calcium channel blockers	2	C08	3	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	calcium channel blockers	1	C08	3	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	calcium channel blockers	2	C08	3	1
35131	HealthPartners Dental Group and Clinics periodontal risk assessment guideline	calcium channel blockers	1	C08	3	1
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	calcium channel blockers	1	C08	3	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	calcium channel blockers	1	C08	3	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	calcium channel blockers	3	C08	3	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	calcium channel blockers	2	C08	3	1
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	calcium channel blockers	3	C08	3	1
46240	Prevention and management of obesity for adults	calcium channel blockers	1	C08	3	1
46241	Stable coronary artery disease	calcium channel blockers	7	C08	3	1
47030	Heart failure in adults	calcium channel blockers	1	C08	3	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	calcium channel blockers	2	C08	3	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	calcium channel blockers	3	C08	3	1
48267	2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	calcium channel blockers	1	C08	3	1
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	calcium channel blockers	1	C08	3	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	calcium channel blockers	3	C08	3	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	amlodipine	2	C08CA01	7	1
23909	Evaluation and therapy for heart failure in the setting of ischemic heart disease: HFSA 2010 comprehensive heart failure practice guideline	amlodipine	1	C08CA01	7	1
23910	Managing patients with hypertension and heart failure: HFSA 2010 comprehensive heart failure practice guideline	amlodipine	2	C08CA01	7	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	amlodipine	1	C08CA01	7	1
24713	Coronary heart disease	amlodipine	1	C08CA01	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	amlodipine	1	C08CA01	7	1
34825	Management of stable angina	amlodipine	2	C08CA01	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	amlodipine	7	C08CA01	7	1
47030	Heart failure in adults	amlodipine	1	C08CA01	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	amlodipine	1	C08CA01	7	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	amlodipine	1	C08CA01	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	felodipine	1	C08CA02	7	1
23909	Evaluation and therapy for heart failure in the setting of ischemic heart disease: HFSA 2010 comprehensive heart failure practice guideline	felodipine	1	C08CA02	7	1
23910	Managing patients with hypertension and heart failure: HFSA 2010 comprehensive heart failure practice guideline	felodipine	2	C08CA02	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	felodipine	1	C08CA02	7	1
34825	Management of stable angina	felodipine	2	C08CA02	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	felodipine	2	C08CA02	7	1
47030	Heart failure in adults	felodipine	1	C08CA02	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	nicardipine	3	C08CA04	7	1
34438	Care of the patient undergoing intracranial pressure monitoring/external ventricular drainage or lumbar drainage	nicardipine	1	C08CA04	7	1
38254	Diagnosis and initial treatment of ischemic stroke	nicardipine	1	C08CA04	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	nifedipine	2	C08CA05	7	1
34113	Cardiometabolic risk management guidelines in primary care	nifedipine	1	C08CA05	7	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	nifedipine	1	C08CA05	7	1
34825	Management of stable angina	nifedipine	2	C08CA05	7	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	nifedipine	1	C08CA05	7	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	nifedipine	2	C08CA05	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	nifedipine	1	C08CA05	7	1
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	nifedipine	1	C08CA05	7	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	nifedipine	1	C08CA05	7	1
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	nifedipine	1	C08CA05	7	1
36825	Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\'s Multidisciplinary Consensus Conference	nimodipine	3	C08CA06	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	nimodipine	2	C08CA06	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	nitrendipine	1	C08CA08	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	verapamil	1	C08DA01	7	1
23907	Evaluation and management of patients with heart failure and preserved left ventricular ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	verapamil	1	C08DA01	7	1
23909	Evaluation and therapy for heart failure in the setting of ischemic heart disease: HFSA 2010 comprehensive heart failure practice guideline	verapamil	1	C08DA01	7	1
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	verapamil	1	C08DA01	7	1
24713	Coronary heart disease	verapamil	1	C08DA01	7	1
33192	Acute coronary syndrome and myocardial infarction	verapamil	1	C08DA01	7	1
34113	Cardiometabolic risk management guidelines in primary care	verapamil	1	C08DA01	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	verapamil	1	C08DA01	7	1
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	verapamil	13	C08DA01	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	verapamil	1	C08DA01	7	1
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	verapamil	1	C08DA01	7	1
47030	Heart failure in adults	verapamil	3	C08DA01	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	verapamil	1	C08DA01	7	1
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	verapamil	2	C08DA01	7	1
48117	Guidelines for the management of absolute cardiovascular disease risk	verapamil	1	C08DA01	7	1
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	verapamil	2	C08DA01	7	1
37941	ACR Appropriateness Criteria&amp;reg; renovascular hypertension	captopril	13	C09AA01	7	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	captopril	2	C09AA01	7	1
47030	Heart failure in adults	captopril	1	C09AA01	7	1
47681	ACR Appropriateness Criteria&amp;reg; renal failure	captopril	1	C09AA01	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	captopril	1	C09AA01	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	enalapril	1	C09AA02	7	1
23910	Managing patients with hypertension and heart failure: HFSA 2010 comprehensive heart failure practice guideline	enalapril	1	C09AA02	7	1
24713	Coronary heart disease	enalapril	1	C09AA02	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	enalapril	2	C09AA02	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	enalapril	2	C09AA02	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	enalapril	2	C09AA02	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	enalapril	1	C09AA02	7	1
48267	2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	enalapril	1	C09AA02	7	1
24713	Coronary heart disease	lisinopril	1	C09AA03	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	lisinopril	1	C09AA03	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	lisinopril	1	C09AA03	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	perindopril	3	C09AA04	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	perindopril	1	C09AA04	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	ramipril	1	C09AA05	7	1
24713	Coronary heart disease	ramipril	1	C09AA05	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	ramipril	1	C09AA05	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	valsartan	1	C09CA03	7	1
39354	European guidelines on cardiovascular disease prevention in clinical practice (version 2012)	valsartan	1	C09CA03	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	valsartan	3	C09CA03	7	1
10587	Management of chronic heart failure. A national clinical guideline	candesartan	1	C09CA06	7	1
15712	Clinical practice guidelines on arterial hypertension. 2007 update	candesartan	2	C09CA06	7	1
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	candesartan	1	C09CA06	7	1
16394	Management of diabetes. A national clinical guideline	simvastatin	2	C10AA01	7	1
24712	Treatment of dyslipidaemias	simvastatin	5	C10AA01	7	1
24713	Coronary heart disease	simvastatin	1	C10AA01	7	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	simvastatin	6	C10AA01	7	1
47783	Lipid management in adults	simvastatin	7	C10AA01	7	1
48337	2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	simvastatin	2	C10AA01	7	1
48784	The Clinical Pharmacogenetics Implementation Consortium guideline for &lt;em&gt;SLCO1B1&lt;/em&gt; and simvastatin-induced myopathy: 2014 update	simvastatin	13	C10AA01	7	1
24712	Treatment of dyslipidaemias	lovastatin	3	C10AA02	7	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	lovastatin	2	C10AA02	7	1
47783	Lipid management in adults	lovastatin	3	C10AA02	7	1
24712	Treatment of dyslipidaemias	pravastatin	3	C10AA03	7	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	pravastatin	2	C10AA03	7	1
47783	Lipid management in adults	pravastatin	3	C10AA03	7	1
48784	The Clinical Pharmacogenetics Implementation Consortium guideline for &lt;em&gt;SLCO1B1&lt;/em&gt; and simvastatin-induced myopathy: 2014 update	pravastatin	3	C10AA03	7	1
24712	Treatment of dyslipidaemias	fluvastatin	3	C10AA04	7	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	fluvastatin	1	C10AA04	7	1
47783	Lipid management in adults	fluvastatin	2	C10AA04	7	1
16394	Management of diabetes. A national clinical guideline	atorvastatin	2	C10AA05	7	1
24712	Treatment of dyslipidaemias	atorvastatin	3	C10AA05	7	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	atorvastatin	2	C10AA05	7	1
47783	Lipid management in adults	atorvastatin	1	C10AA05	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	atorvastatin	1	C10AA05	7	1
48406	Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease	atorvastatin	9	C10AA05	7	1
48784	The Clinical Pharmacogenetics Implementation Consortium guideline for &lt;em&gt;SLCO1B1&lt;/em&gt; and simvastatin-induced myopathy: 2014 update	atorvastatin	1	C10AA05	7	1
24712	Treatment of dyslipidaemias	rosuvastatin	3	C10AA07	7	1
25310	2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	rosuvastatin	1	C10AA07	7	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	rosuvastatin	2	C10AA07	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	rosuvastatin	1	C10AA07	7	1
47783	Lipid management in adults	rosuvastatin	3	C10AA07	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	rosuvastatin	1	C10AA07	7	1
48784	The Clinical Pharmacogenetics Implementation Consortium guideline for &lt;em&gt;SLCO1B1&lt;/em&gt; and simvastatin-induced myopathy: 2014 update	rosuvastatin	4	C10AA07	7	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	pitavastatin	1	C10AA08	7	1
47783	Lipid management in adults	pitavastatin	1	C10AA08	7	1
48784	The Clinical Pharmacogenetics Implementation Consortium guideline for &lt;em&gt;SLCO1B1&lt;/em&gt; and simvastatin-induced myopathy: 2014 update	pitavastatin	1	C10AA08	7	1
48117	Guidelines for the management of absolute cardiovascular disease risk	clofibrate	1	C10AB01	7	1
48337	2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	clofibrate	3	C10AB01	7	1
24712	Treatment of dyslipidaemias	bezafibrate	3	C10AB02	7	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	bezafibrate	1	C10AB02	7	1
14329	Identification and management of familial hypercholesterolaemia	gemfibrozil	1	C10AB04	7	1
15711	Clinical practice guideline on the management of lipids as a cardiovascular risk factor	gemfibrozil	1	C10AB04	7	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	gemfibrozil	2	C10AB04	7	1
24712	Treatment of dyslipidaemias	gemfibrozil	3	C10AB04	7	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	gemfibrozil	13	C10AB04	7	1
47783	Lipid management in adults	gemfibrozil	6	C10AB04	7	1
48337	2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	gemfibrozil	1	C10AB04	7	1
48950	VA/DoD clinical practice guideline for the management of dyslipidemia for cardiovascular risk reduction	gemfibrozil	2	C10AB04	7	1
24712	Treatment of dyslipidaemias	fenofibrate	4	C10AB05	7	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	fenofibrate	2	C10AB05	7	1
43854	"Prevention of vascular and metabolic disease. In: Guidelines for preventive activities in general practice, 8th edition"	fenofibrate	1	C10AB05	7	1
47783	Lipid management in adults	fenofibrate	8	C10AB05	7	1
48117	Guidelines for the management of absolute cardiovascular disease risk	fenofibrate	1	C10AB05	7	1
48337	2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	fenofibrate	6	C10AB05	7	1
14329	Identification and management of familial hypercholesterolaemia	bile acid sequestrants	2	C10AC	5	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	bile acid sequestrants	5	C10AC	5	1
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	bile acid sequestrants	1	C10AC	5	1
48337	2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	bile acid sequestrants	1	C10AC	5	1
48406	Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease	bile acid sequestrants	1	C10AC	5	1
48950	VA/DoD clinical practice guideline for the management of dyslipidemia for cardiovascular risk reduction	bile acid sequestrants	1	C10AC	5	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	colestipol	1	C10AC02	7	1
47783	Lipid management in adults	colestipol	3	C10AC02	7	1
24712	Treatment of dyslipidaemias	colesevelam	2	C10AC04	7	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	colesevelam	3	C10AC04	7	1
47783	Lipid management in adults	colesevelam	1	C10AC04	7	1
14329	Identification and management of familial hypercholesterolaemia	ezetimibe	9	C10AX09	7	1
15711	Clinical practice guideline on the management of lipids as a cardiovascular risk factor	ezetimibe	3	C10AX09	7	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	ezetimibe	2	C10AX09	7	1
24712	Treatment of dyslipidaemias	ezetimibe	6	C10AX09	7	1
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	ezetimibe	3	C10AX09	7	1
43788	KDOQI clinical practice guideline for diabetes and CKD: 2012 update&lt;/div&gt;	ezetimibe	1	C10AX09	7	1
43854	"Prevention of vascular and metabolic disease. In: Guidelines for preventive activities in general practice, 8th edition"	ezetimibe	1	C10AX09	7	1
47699	KDIGO clinical practice guideline for lipid management in chronic kidney disease	ezetimibe	4	C10AX09	7	1
47783	Lipid management in adults	ezetimibe	9	C10AX09	7	1
47920	Management of chronic kidney disease	ezetimibe	1	C10AX09	7	1
48117	Guidelines for the management of absolute cardiovascular disease risk	ezetimibe	2	C10AX09	7	1
48337	2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	ezetimibe	3	C10AX09	7	1
48406	Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease	ezetimibe	3	C10AX09	7	1
48950	VA/DoD clinical practice guideline for the management of dyslipidemia for cardiovascular risk reduction	ezetimibe	1	C10AX09	7	1
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	ketoconazole	1	D01AC08	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	ketoconazole	1	D01AC08	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	fluconazole	1	D01AC15	7	1
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	hyaluronic acid	1	D03AX05	7	1
46422	"American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis of the knee, 2nd edition"	hyaluronic acid	1	D03AX05	7	1
48530	VA/DoD clinical practice guideline for the non-surgical management of hip and knee osteoarthritis	hyaluronic acid	1	D03AX05	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	diphenhydramine	1	D04AA32	7	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	mupirocin	2	D06AX09	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	methylprednisolone	1	D07AA01	7	1
36895	Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology	methylprednisolone	1	D07AA01	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	methylprednisolone	1	D07AA01	7	1
38255	Diagnosis and management of asthma	methylprednisolone	2	D07AA01	7	1
32491	COPD management in the long-term care setting	fluticasone	1	D07AC17	7	1
38897	Chronic obstructive pulmonary disease (COPD)	fluticasone	1	D07AC17	7	1
34438	Care of the patient undergoing intracranial pressure monitoring/external ventricular drainage or lumbar drainage	iodine	4	D08AG03	7	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	iodine	1	D08AG03	7	1
43766	"Preventive activities prior to pregnancy. In: Guidelines for preventive activities in general practice, 8th edition"	iodine	3	D08AG03	7	1
43853	"Prevention of chronic disease. In: Guidelines for preventive activities in general practice, 8th edition"	iodine	1	D08AG03	7	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	iodine	1	D08AG03	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	iodine	1	D08AG03	7	1
48285	ACR Appropriateness Criteria&amp;reg; dementia and movement disorders	iodine	3	D08AG03	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	silver	1	D08AL30	7	0
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	sodium hypochlorite	1	D08AX07	7	1
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	ethanol	1	D08AX08	7	0
37915	ACR Appropriateness Criteria&amp;reg; suspected osteomyelitis of the foot in patients with diabetes mellitus	sulfur	10	D10AB02	7	0
47315	Adult depression in primary care	isotretinoin	1	D10AD04	7	1
34113	Cardiometabolic risk management guidelines in primary care	erythromycin	1	D10AF02	7	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	erythromycin	1	D10AF02	7	1
47783	Lipid management in adults	erythromycin	1	D10AF02	7	1
37288	Guidelines for the prevention and management of &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; infection and disease in adult patients with chronic kidney disease	tacrolimus	1	D11AH01	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	tacrolimus	4	D11AH01	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	tacrolimus	1	D11AH01	7	1
47151	Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation	tacrolimus	4	D11AH01	7	1
47783	Lipid management in adults	tacrolimus	1	D11AH01	7	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	diclofenac	1	D11AX18	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	diclofenac	1	D11AX18	7	1
47681	ACR Appropriateness Criteria&amp;reg; renal failure	acetic acid	1	G01AD02	7	0
38470	EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia	bromocriptine	1	G02CB01	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	bromocriptine	1	G02CB01	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	naproxen	1	G02CC02	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	naproxen	1	G02CC02	7	1
15428	Noncontraceptive uses of hormonal contraceptives	levonorgestrel	1	G03AC03	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	levonorgestrel	1	G03AC03	7	1
34113	Cardiometabolic risk management guidelines in primary care	megestrol	1	G03AC05	7	1
15428	Noncontraceptive uses of hormonal contraceptives	medroxyprogesterone	1	G03AC06	7	1
39382	Taiwan osteoporosis practice guidelines	medroxyprogesterone	1	G03AC06	7	1
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	medroxyprogesterone	1	G03AC06	7	1
34281	Anaemia management in people with chronic kidney disease	androgens	2	G03B	4	0
38245	KDIGO clinical practice guideline for anemia in chronic kidney disease	androgens	1	G03B	4	0
34113	Cardiometabolic risk management guidelines in primary care	testosterone	2	G03BA03	7	1
34900	Late (complicated) Parkinson\'s disease	testosterone	1	G03BA03	7	1
37827	Osteoporosis in men: an Endocrine Society clinical practice guideline	testosterone	9	G03BA03	7	1
39382	Taiwan osteoporosis practice guidelines	testosterone	1	G03BA03	7	1
47543	Diagnosis and treatment of osteoporosis	testosterone	4	G03BA03	7	1
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	testosterone	3	G03BA03	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	testosterone	1	G03BA03	7	1
39382	Taiwan osteoporosis practice guidelines	estradiol	3	G03CA03	7	1
47543	Diagnosis and treatment of osteoporosis	estradiol	1	G03CA03	7	1
39382	Taiwan osteoporosis practice guidelines	estrone	1	G03CA07	7	0
39382	Taiwan osteoporosis practice guidelines	tibolone	5	G03CX01	7	
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	tibolone	1	G03CX01	7	
34113	Cardiometabolic risk management guidelines in primary care	hydroxyprogesterone	1	G03DA03	7	1
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	progesterone	1	G03DA04	7	1
34286	"Osteoporosis: diagnosis, treatment, and fracture prevention"	progesterone	2	G03DA04	7	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	progesterone	1	G03DA04	7	1
39382	Taiwan osteoporosis practice guidelines	progesterone	1	G03DA04	7	1
47543	Diagnosis and treatment of osteoporosis	progesterone	1	G03DA04	7	1
37920	ACR Appropriateness Criteria&amp;reg; neuroendocrine imaging	gonadotropins	2	G03GA	5	
23824	ACR Appropriateness Criteria&amp;reg; osteoporosis and bone mineral density	selective estrogen receptor modulators	1	G03XC	5	1
34286	"Osteoporosis: diagnosis, treatment, and fracture prevention"	selective estrogen receptor modulators	2	G03XC	5	1
39382	Taiwan osteoporosis practice guidelines	selective estrogen receptor modulators	1	G03XC	5	1
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	selective estrogen receptor modulators	1	G03XC	5	1
25316	Screening for osteoporosis: U.S. Preventive Services Task Force recommendation statement	raloxifene	1	G03XC01	7	1
34286	"Osteoporosis: diagnosis, treatment, and fracture prevention"	raloxifene	6	G03XC01	7	1
34968	American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis	raloxifene	1	G03XC01	7	1
35236	Osteoporosis: prevention and treatment	raloxifene	1	G03XC01	7	1
38413	Osteoporosis	raloxifene	1	G03XC01	7	1
38537	Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement	raloxifene	1	G03XC01	7	1
39382	Taiwan osteoporosis practice guidelines	raloxifene	3	G03XC01	7	1
47543	Diagnosis and treatment of osteoporosis	raloxifene	9	G03XC01	7	1
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	raloxifene	1	G03XC01	7	1
34900	Late (complicated) Parkinson\'s disease	oxybutynin	2	G04BD04	7	1
34900	Late (complicated) Parkinson\'s disease	tolterodine	2	G04BD07	7	
34900	Late (complicated) Parkinson\'s disease	trospium	2	G04BD09	7	0
23902	Nonpharmacologic management and health care maintenance of patients with chronic heart failure: HFSA 2010 comprehensive heart failure practice guideline	sildenafil	1	G04BE03	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	sildenafil	1	G04BE03	7	1
34900	Late (complicated) Parkinson\'s disease	sildenafil	1	G04BE03	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	sildenafil	1	G04BE03	7	1
46241	Stable coronary artery disease	sildenafil	2	G04BE03	7	1
34900	Late (complicated) Parkinson\'s disease	apomorphine	6	G04BE07	7	1
36628	Clinical practice guideline for type 2 diabetes	apomorphine	1	G04BE07	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	apomorphine	1	G04BE07	7	1
34900	Late (complicated) Parkinson\'s disease	tadalafil	1	G04BE08	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	tadalafil	1	G04BE08	7	1
46241	Stable coronary artery disease	tadalafil	2	G04BE08	7	1
34900	Late (complicated) Parkinson\'s disease	vardenafil	1	G04BE09	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	vardenafil	1	G04BE09	7	1
46241	Stable coronary artery disease	vardenafil	2	G04BE09	7	1
36825	Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\'s Multidisciplinary Consensus Conference	vasopressin	1	H01BA01	7	1
37920	ACR Appropriateness Criteria&amp;reg; neuroendocrine imaging	vasopressin	1	H01BA01	7	1
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	vasopressin	3	H01BA01	7	1
37920	ACR Appropriateness Criteria&amp;reg; neuroendocrine imaging	oxytocin	1	H01BB02	7	1
37920	ACR Appropriateness Criteria&amp;reg; neuroendocrine imaging	somatostatin	1	H01CB01	7	1
35255	Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline	octreotide	1	H01CB02	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	octreotide	1	H01CB02	7	1
10585	Acute coronary syndromes. A national clinical guideline	aldosterone	1	H02AA01	7	0
23900	Evaluation of patients for ventricular dysfunction and heart failure: HFSA 2010 comprehensive heart failure practice guideline	aldosterone	1	H02AA01	7	0
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	aldosterone	10	H02AA01	7	0
23910	Managing patients with hypertension and heart failure: HFSA 2010 comprehensive heart failure practice guideline	aldosterone	1	H02AA01	7	0
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	aldosterone	8	H02AA01	7	0
32492	Heart failure in the long-term care setting	aldosterone	1	H02AA01	7	0
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	aldosterone	2	H02AA01	7	0
39220	Ivabradine for treating chronic heart failure	aldosterone	2	H02AA01	7	0
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	aldosterone	1	H02AA01	7	0
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	aldosterone	2	H02AA01	7	0
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	aldosterone	1	H02AA01	7	0
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	aldosterone	2	H02AA01	7	0
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	aldosterone	2	H02AA01	7	0
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	aldosterone	4	H02AA01	7	0
47030	Heart failure in adults	aldosterone	8	H02AA01	7	0
47084	Heart failure - systolic dysfunction	aldosterone	2	H02AA01	7	0
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	aldosterone	7	H02AA01	7	0
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	aldosterone	7	H02AA01	7	0
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	aldosterone	3	H02AA01	7	0
47920	Management of chronic kidney disease	aldosterone	1	H02AA01	7	0
48221	Secondary prevention of ischemic heart disease and stroke in adults	aldosterone	3	H02AA01	7	0
48267	2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	aldosterone	1	H02AA01	7	0
48544	Diagnosis and management of type 2 diabetes mellitus in adults	aldosterone	1	H02AA01	7	0
48752	Acute heart failure: diagnosing and managing acute heart failure in adults	aldosterone	3	H02AA01	7	0
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	aldosterone	1	H02AA01	7	0
48951	VA/DoD clinical practice guideline for the management of chronic kidney disease in primary care	aldosterone	1	H02AA01	7	0
34900	Late (complicated) Parkinson\'s disease	fludrocortisone	1	H02AA02	7	1
36825	Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\'s Multidisciplinary Consensus Conference	fludrocortisone	2	H02AA02	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	cortisone	1	H02AB10	7	0
16394	Management of diabetes. A national clinical guideline	glucagon	1	H04AA01	7	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	glucagon	1	H04AA01	7	1
35239	Diabetes management at camps for children with diabetes	glucagon	2	H04AA01	7	1
37691	Allergen immunotherapy: a practice parameter third update	glucagon	1	H04AA01	7	1
47068	Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes	glucagon	1	H04AA01	7	1
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	glucagon	2	H04AA01	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	glucagon	7	H04AA01	7	1
32422	American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis	teriparatide	3	H05AA02	7	1
34286	"Osteoporosis: diagnosis, treatment, and fracture prevention"	teriparatide	4	H05AA02	7	1
34968	American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis	teriparatide	1	H05AA02	7	1
35236	Osteoporosis: prevention and treatment	teriparatide	2	H05AA02	7	1
37827	Osteoporosis in men: an Endocrine Society clinical practice guideline	teriparatide	3	H05AA02	7	1
47543	Diagnosis and treatment of osteoporosis	teriparatide	4	H05AA02	7	1
23824	ACR Appropriateness Criteria&amp;reg; osteoporosis and bone mineral density	parathyroid hormone	1	H05AA03	7	1
23924	Chronic kidney disease evidence-based nutrition practice guideline	parathyroid hormone	1	H05AA03	7	1
25311	Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society clinical practice guideline	parathyroid hormone	1	H05AA03	7	1
25316	Screening for osteoporosis: U.S. Preventive Services Task Force recommendation statement	parathyroid hormone	1	H05AA03	7	1
34286	"Osteoporosis: diagnosis, treatment, and fracture prevention"	parathyroid hormone	2	H05AA03	7	1
37827	Osteoporosis in men: an Endocrine Society clinical practice guideline	parathyroid hormone	1	H05AA03	7	1
38413	Osteoporosis	parathyroid hormone	1	H05AA03	7	1
39382	Taiwan osteoporosis practice guidelines	parathyroid hormone	2	H05AA03	7	1
44088	Hyperphosphataemia in chronic kidney disease. Management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease	parathyroid hormone	2	H05AA03	7	1
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	parathyroid hormone	1	H05AA03	7	1
46648	Diagnosis and management of adults with chronic kidney disease	parathyroid hormone	1	H05AA03	7	1
47543	Diagnosis and treatment of osteoporosis	parathyroid hormone	4	H05AA03	7	1
48951	VA/DoD clinical practice guideline for the management of chronic kidney disease in primary care	parathyroid hormone	1	H05AA03	7	1
32491	COPD management in the long-term care setting	ampicillin	1	J01CA01	7	1
32491	COPD management in the long-term care setting	amoxicillin	2	J01CA04	7	1
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	amoxicillin	2	J01CA04	7	1
35922	Consultation and referral guidelines citing the evidence: how the allergist/immunologist can help	trimethoprim	1	J01EA01	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	trimethoprim	1	J01EA01	7	1
47151	Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation	trimethoprim	1	J01EA01	7	1
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	trimethoprim	1	J01EA01	7	1
35922	Consultation and referral guidelines citing the evidence: how the allergist/immunologist can help	sulfamethoxazole	1	J01EC01	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	sulfamethoxazole	1	J01EC01	7	1
47151	Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation	sulfamethoxazole	1	J01EC01	7	1
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	sulfamethoxazole	1	J01EC01	7	1
32491	COPD management in the long-term care setting	macrolides	1	J01FA	5	1
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	macrolides	1	J01FA	5	1
34113	Cardiometabolic risk management guidelines in primary care	clarithromycin	1	J01FA09	7	1
47783	Lipid management in adults	clarithromycin	1	J01FA09	7	1
48784	The Clinical Pharmacogenetics Implementation Consortium guideline for &lt;em&gt;SLCO1B1&lt;/em&gt; and simvastatin-induced myopathy: 2014 update	clarithromycin	1	J01FA09	7	1
34113	Cardiometabolic risk management guidelines in primary care	azithromycin	1	J01FA10	7	1
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	azithromycin	2	J01FA10	7	1
47783	Lipid management in adults	azithromycin	1	J01FA10	7	1
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	azithromycin	1	J01FA10	7	1
47783	Lipid management in adults	telithromycin	1	J01FA15	7	1
37288	Guidelines for the prevention and management of &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; infection and disease in adult patients with chronic kidney disease	rifampicin	7	J04AB02	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	rifampicin	3	J04AB02	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	rifabutin	1	J04AB04	7	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	isoniazid	1	J04AC01	7	1
37288	Guidelines for the prevention and management of &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; infection and disease in adult patients with chronic kidney disease	isoniazid	6	J04AC01	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	isoniazid	1	J04AC01	7	1
37288	Guidelines for the prevention and management of &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; infection and disease in adult patients with chronic kidney disease	pyrazinamide	3	J04AK01	7	1
37288	Guidelines for the prevention and management of &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; infection and disease in adult patients with chronic kidney disease	ethambutol	4	J04AK02	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	ribavirin	2	J05AB04	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	ribavirin	2	J05AB04	7	1
47151	Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation	ganciclovir	3	J05AB06	7	1
47151	Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation	cidofovir	1	J05AB12	7	1
47151	Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation	foscarnet	1	J05AD01	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	ritonavir	11	J05AE03	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	fosamprenavir	2	J05AE07	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	atazanavir	2	J05AE08	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	tipranavir	1	J05AE09	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	darunavir	2	J05AE10	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	telaprevir	2	J05AE11	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	boceprevir	1	J05AE12	7	1
48784	The Clinical Pharmacogenetics Implementation Consortium guideline for &lt;em&gt;SLCO1B1&lt;/em&gt; and simvastatin-induced myopathy: 2014 update	boceprevir	1	J05AE12	7	1
39393	Kidney disease in HIV-infected patients	zidovudine	3	J05AF01	7	1
48210	The official positions of the International Society for Clinical Densitometry: indications of use and reporting of DXA for body composition	zidovudine	1	J05AF01	7	1
39393	Kidney disease in HIV-infected patients	didanosine	3	J05AF02	7	1
39393	Kidney disease in HIV-infected patients	stavudine	1	J05AF04	7	1
48210	The official positions of the International Society for Clinical Densitometry: indications of use and reporting of DXA for body composition	stavudine	1	J05AF04	7	1
39393	Kidney disease in HIV-infected patients	lamivudine	4	J05AF05	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	lamivudine	2	J05AF05	7	1
39393	Kidney disease in HIV-infected patients	abacavir	2	J05AF06	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	abacavir	2	J05AF06	7	1
39393	Kidney disease in HIV-infected patients	emtricitabine	5	J05AF09	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	emtricitabine	3	J05AF09	7	1
34265	Depression and mania in patients with HIV/AIDS	non-nucleoside reverse transcriptase inhibitors	1	J05AG	5	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	nevirapine	2	J05AG01	7	1
39393	Kidney disease in HIV-infected patients	efavirenz	1	J05AG03	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	efavirenz	2	J05AG03	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	etravirine	1	J05AG04	7	1
39393	Kidney disease in HIV-infected patients	rilpivirine	1	J05AG05	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	rilpivirine	2	J05AG05	7	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	zanamivir	2	J05AH01	7	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	oseltamivir	2	J05AH02	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	raltegravir	2	J05AX08	7	1
39393	Kidney disease in HIV-infected patients	maraviroc	1	J05AX09	7	
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	maraviroc	1	J05AX09	7	
39393	Kidney disease in HIV-infected patients	elvitegravir	1	J05AX11	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	elvitegravir	2	J05AX11	7	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	vaccines	2	J07	3	0
36892	2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis	vaccines	1	J07	3	0
37694	Assessing heart failure in long term care facilities	vaccines	2	J07	3	0
38244	KDIGO clinical practice guideline for glomerulonephritis	vaccines	3	J07	3	0
38460	Basic guidelines for diabetes care	vaccines	2	J07	3	0
38656	BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies	vaccines	1	J07	3	0
43766	"Preventive activities prior to pregnancy. In: Guidelines for preventive activities in general practice, 8th edition"	vaccines	1	J07	3	0
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	vaccines	6	J07	3	0
46648	Diagnosis and management of adults with chronic kidney disease	vaccines	1	J07	3	0
46649	Adult preventive services (ages 18-49)	vaccines	1	J07	3	0
46650	Adult preventive services (ages 50 - 65+)	vaccines	1	J07	3	0
47151	Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation	vaccines	1	J07	3	0
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	vaccines	1	J07	3	0
48951	VA/DoD clinical practice guideline for the management of chronic kidney disease in primary care	vaccines	1	J07	3	0
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	pertussis vaccines	1	J07AJ	5	1
37694	Assessing heart failure in long term care facilities	pneumococcal vaccines	1	J07AL	5	1
43766	"Preventive activities prior to pregnancy. In: Guidelines for preventive activities in general practice, 8th edition"	viral vaccines	1	J07B	4	1
37694	Assessing heart failure in long term care facilities	influenza vaccines	1	J07BB	5	1
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	influenza vaccines	1	J07BB	5	1
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	influenza vaccines	1	J07BB	5	1
38244	KDIGO clinical practice guideline for glomerulonephritis	alkylating agents	5	L01A	4	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	cyclophosphamide	3	L01AA01	7	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	cyclophosphamide	2	L01AA01	7	1
36874	Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline	cyclophosphamide	2	L01AA01	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	cyclophosphamide	28	L01AA01	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	cyclophosphamide	3	L01AA01	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	chlorambucil	5	L01AA02	7	1
24599	Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 revision	antimetabolites	1	L01B	4	1
24111	"Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor"	methotrexate	8	L01BA01	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	methotrexate	2	L01BA01	7	1
34950	Management of early rheumatoid arthritis. A national clinical guideline	methotrexate	1	L01BA01	7	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	methotrexate	1	L01BA01	7	1
36890	Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198)	methotrexate	1	L01BA01	7	1
36892	2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis	methotrexate	8	L01BA01	7	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	methotrexate	1	L01BA01	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	methotrexate	1	L01BA01	7	1
38655	BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis	methotrexate	1	L01BA01	7	1
38656	BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies	methotrexate	1	L01BA01	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	methotrexate	1	L01BA01	7	1
39244	"Rheumatoid arthritis: diagnosis, management and monitoring"	methotrexate	1	L01BA01	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	methotrexate	7	L01BA01	7	1
45126	Abatacept for treating rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs (rapid review of technology appraisal guidance 234)	methotrexate	2	L01BA01	7	1
48457	"International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma"	methotrexate	6	L01BA01	7	1
43955	Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing	mercaptopurine	2	L01BB02	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	vinblastine	1	L01CA01	7	1
36874	Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline	vincristine	3	L01CA02	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	vincristine	1	L01CA02	7	1
46241	Stable coronary artery disease	paclitaxel	1	L01CD01	7	1
36874	Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline	doxorubicin	1	L01DB01	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	doxorubicin	1	L01DB01	7	1
36874	Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline	bleomycin	1	L01DC01	7	1
36874	Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline	carboplatin	1	L01XA02	7	1
24111	"Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor"	rituximab	13	L01XC02	7	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	rituximab	1	L01XC02	7	1
36890	Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198)	rituximab	6	L01XC02	7	1
36892	2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis	rituximab	2	L01XC02	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	rituximab	5	L01XC02	7	1
38655	BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis	rituximab	21	L01XC02	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	trastuzumab	1	L01XC03	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	bevacizumab	2	L01XC07	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	imatinib	1	L01XE01	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	sunitinib	1	L01XE04	7	1
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	irinotecan	1	L01XX19	7	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	celecoxib	1	L01XX33	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	tamoxifen	2	L02BA01	7	1
38537	Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement	tamoxifen	1	L02BA01	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	tamoxifen	1	L02BA01	7	1
47543	Diagnosis and treatment of osteoporosis	tamoxifen	1	L02BA01	7	1
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	tamoxifen	1	L02BA01	7	1
38410	Osteoporosis: assessing the risk of fragility fracture	aromatase inhibitors	1	L02BG	5	1
43860	"Osteoporosis. In: Guidelines for preventive activities in general practice, 8th edition"	aromatase inhibitors	1	L02BG	5	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	filgrastim	1	L03AA02	7	1
37288	Guidelines for the prevention and management of &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; infection and disease in adult patients with chronic kidney disease	interferon gamma	1	L03AB03	7	1
36895	Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology	immunosuppressants	1	L04	3	1
38655	BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis	immunosuppressants	1	L04	3	1
43955	Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing	immunosuppressants	1	L04	3	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	mycophenolic acid	2	L04AA06	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	sirolimus	6	L04AA10	7	1
46241	Stable coronary artery disease	sirolimus	1	L04AA10	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	leflunomide	2	L04AA13	7	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	leflunomide	1	L04AA13	7	1
36892	2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis	leflunomide	1	L04AA13	7	1
38655	BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis	leflunomide	1	L04AA13	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	leflunomide	4	L04AA13	7	1
24111	"Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor"	abatacept	5	L04AA24	7	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	abatacept	1	L04AA24	7	1
36890	Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198)	abatacept	2	L04AA24	7	1
36892	2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis	abatacept	1	L04AA24	7	1
45126	Abatacept for treating rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs (rapid review of technology appraisal guidance 234)	abatacept	3	L04AA24	7	1
24110	Certolizumab pegol for the treatment of rheumatoid arthritis	etanercept	1	L04AB01	7	1
24111	"Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor"	etanercept	7	L04AB01	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	etanercept	1	L04AB01	7	1
36890	Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198)	etanercept	3	L04AB01	7	1
36892	2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis	etanercept	1	L04AB01	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	etanercept	1	L04AB01	7	1
38655	BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis	etanercept	1	L04AB01	7	1
38656	BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies	etanercept	4	L04AB01	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	etanercept	3	L04AB01	7	1
45126	Abatacept for treating rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs (rapid review of technology appraisal guidance 234)	etanercept	1	L04AB01	7	1
24110	Certolizumab pegol for the treatment of rheumatoid arthritis	infliximab	1	L04AB02	7	1
24111	"Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor"	infliximab	5	L04AB02	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	infliximab	1	L04AB02	7	1
36890	Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198)	infliximab	3	L04AB02	7	1
36892	2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis	infliximab	1	L04AB02	7	1
38655	BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis	infliximab	1	L04AB02	7	1
38656	BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies	infliximab	4	L04AB02	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	infliximab	3	L04AB02	7	1
45126	Abatacept for treating rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs (rapid review of technology appraisal guidance 234)	infliximab	1	L04AB02	7	1
24110	Certolizumab pegol for the treatment of rheumatoid arthritis	adalimumab	1	L04AB04	7	1
24111	"Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor"	adalimumab	7	L04AB04	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	adalimumab	1	L04AB04	7	1
36890	Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198)	adalimumab	3	L04AB04	7	1
38655	BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis	adalimumab	1	L04AB04	7	1
38656	BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies	adalimumab	4	L04AB04	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	adalimumab	3	L04AB04	7	1
45126	Abatacept for treating rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs (rapid review of technology appraisal guidance 234)	adalimumab	1	L04AB04	7	1
24110	Certolizumab pegol for the treatment of rheumatoid arthritis	certolizumab pegol	3	L04AB05	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	daclizumab	1	L04AC01	7	1
47572	Asthma. In: Pulmonary (acute &amp;amp; chronic)&lt;/div&gt;	daclizumab	1	L04AC01	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	basiliximab	1	L04AC02	7	1
36890	Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198)	tocilizumab	4	L04AC07	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	calcineurin inhibitors	1	L04AD	5	1
39430	KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease	calcineurin inhibitors	1	L04AD	5	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	calcineurin inhibitors	1	L04AD	5	1
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	calcineurin inhibitors	1	L04AD	5	1
37288	Guidelines for the prevention and management of &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; infection and disease in adult patients with chronic kidney disease	ciclosporin	1	L04AD01	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	azathioprine	1	L04AX01	7	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	azathioprine	1	L04AX01	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	azathioprine	13	L04AX01	7	1
43955	Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing	azathioprine	9	L04AX01	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	azathioprine	3	L04AX01	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	thalidomide	4	L04AX02	7	1
35259	Practice guidelines for acute pain management in the perioperative setting. An updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management	coxibs	1	M01AH	5	0
47862	Osteoarthritis. Care and management in adults	etoricoxib	1	M01AH05	7	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	glucosamine	1	M01AX05	7	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	glucosamine	3	M01AX05	7	1
46422	"American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis of the knee, 2nd edition"	glucosamine	1	M01AX05	7	1
47862	Osteoarthritis. Care and management in adults	glucosamine	1	M01AX05	7	1
48530	VA/DoD clinical practice guideline for the non-surgical management of hip and knee osteoarthritis	glucosamine	1	M01AX05	7	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	diacerein	1	M01AX21	7	
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	chondroitin sulfate	1	M01AX25	7	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	chondroitin sulfate	3	M01AX25	7	1
48530	VA/DoD clinical practice guideline for the non-surgical management of hip and knee osteoarthritis	chondroitin sulfate	1	M01AX25	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	penicillamine	4	M01CC01	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	capsaicin	3	M02AB01	7	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	capsaicin	1	M02AB01	7	1
36628	Clinical practice guideline for type 2 diabetes	capsaicin	1	M02AB01	7	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	capsaicin	2	M02AB01	7	1
47862	Osteoarthritis. Care and management in adults	capsaicin	1	M02AB01	7	1
48530	VA/DoD clinical practice guideline for the non-surgical management of hip and knee osteoarthritis	capsaicin	3	M02AB01	7	1
24174	Managing complications. In: Clinical guidelines for stroke management 2010	botulinum toxin	1	M03AX01	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	botulinum toxin	2	M03AX01	7	1
34091	Stroke rehabilitation. In: Canadian best practice recommendations for stroke care	botulinum toxin	3	M03AX01	7	1
34900	Late (complicated) Parkinson\'s disease	botulinum toxin	3	M03AX01	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	baclofen	2	M03BX01	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	baclofen	1	M03BX01	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	tizanidine	2	M03BX02	7	1
34091	Stroke rehabilitation. In: Canadian best practice recommendations for stroke care	tizanidine	2	M03BX02	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	tizanidine	1	M03BX02	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	cyclobenzaprine	1	M03BX08	7	1
43946	Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines	allopurinol	3	M04AA01	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	allopurinol	1	M04AA01	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	colchicine	1	M04AC01	7	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	colchicine	1	M04AC01	7	1
32422	American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis	zoledronic acid	5	M05BA08	7	1
34286	"Osteoporosis: diagnosis, treatment, and fracture prevention"	zoledronic acid	3	M05BA08	7	1
34968	American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis	zoledronic acid	1	M05BA08	7	1
35236	Osteoporosis: prevention and treatment	zoledronic acid	1	M05BA08	7	1
37827	Osteoporosis in men: an Endocrine Society clinical practice guideline	zoledronic acid	2	M05BA08	7	1
39382	Taiwan osteoporosis practice guidelines	zoledronic acid	3	M05BA08	7	1
47543	Diagnosis and treatment of osteoporosis	zoledronic acid	5	M05BA08	7	1
47543	Diagnosis and treatment of osteoporosis	ipriflavone	1	M05BX01	7	0
24798	American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of symptomatic osteoporotic spinal compression fractures	strontium ranelate	1	M05BX03	7	1
37827	Osteoporosis in men: an Endocrine Society clinical practice guideline	strontium ranelate	1	M05BX03	7	1
39382	Taiwan osteoporosis practice guidelines	strontium ranelate	6	M05BX03	7	1
47543	Diagnosis and treatment of osteoporosis	strontium ranelate	1	M05BX03	7	1
34286	"Osteoporosis: diagnosis, treatment, and fracture prevention"	denosumab	3	M05BX04	7	1
34968	American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis	denosumab	1	M05BX04	7	1
35236	Osteoporosis: prevention and treatment	denosumab	2	M05BX04	7	1
37827	Osteoporosis in men: an Endocrine Society clinical practice guideline	denosumab	1	M05BX04	7	1
38413	Osteoporosis	denosumab	1	M05BX04	7	1
47543	Diagnosis and treatment of osteoporosis	denosumab	3	M05BX04	7	1
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	anesthetics	2	N01	3	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	anesthetics	2	N01	3	1
35259	Practice guidelines for acute pain management in the perioperative setting. An updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management	anesthetics	2	N01	3	1
35922	Consultation and referral guidelines citing the evidence: how the allergist/immunologist can help	anesthetics	2	N01	3	1
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	desflurane	1	N01AB07	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	fentanyl	4	N01AH01	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	sufentanil	1	N01AH03	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	ketamine	1	N01AX03	7	1
38255	Diagnosis and management of asthma	ketamine	5	N01AX03	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	etomidate	1	N01AX07	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	propofol	1	N01AX10	7	1
38255	Diagnosis and management of asthma	propofol	1	N01AX10	7	1
48368	Guidelines for laparoscopic peritoneal dialysis access surgery	nitrous oxide	1	N01AX13	7	1
32645	ACR Appropriateness Criteria&amp;reg; cerebrovascular disease	xenon	1	N01AX15	7	0
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	local anesthetics	2	N01B	4	1
35259	Practice guidelines for acute pain management in the perioperative setting. An updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management	local anesthetics	2	N01B	4	1
35922	Consultation and referral guidelines citing the evidence: how the allergist/immunologist can help	local anesthetics	2	N01B	4	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	prilocaine	1	N01BB04	7	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	cocaine	1	N01BC01	7	0
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	cocaine	2	N01BC01	7	0
46240	Prevention and management of obesity for adults	cocaine	1	N01BC01	7	0
47315	Adult depression in primary care	cocaine	3	N01BC01	7	0
47588	Mental illness &amp;amp; stress	cocaine	2	N01BC01	7	0
47783	Lipid management in adults	cocaine	2	N01BC01	7	0
24798	American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of symptomatic osteoporotic spinal compression fractures	analgesics	1	N02	3	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	analgesics	1	N02	3	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	analgesics	16	N02	3	1
34091	Stroke rehabilitation. In: Canadian best practice recommendations for stroke care	analgesics	1	N02	3	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	analgesics	1	N02	3	1
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	analgesics	1	N02	3	1
34950	Management of early rheumatoid arthritis. A national clinical guideline	analgesics	1	N02	3	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	analgesics	1	N02	3	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	analgesics	5	N02	3	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	analgesics	2	N02	3	1
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	analgesics	1	N02	3	1
47806	Medical management of adults with osteoarthritis	analgesics	2	N02	3	1
47862	Osteoarthritis. Care and management in adults	analgesics	4	N02	3	1
47865	Clinical practice guideline for diabetes mellitus type 1	analgesics	1	N02	3	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	opioid analgesics	5	N02A	4	1
47862	Osteoarthritis. Care and management in adults	opioid analgesics	1	N02A	4	1
16392	Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin	morphine	1	N02AA01	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	morphine	2	N02AA01	7	1
33192	Acute coronary syndrome and myocardial infarction	morphine	2	N02AA01	7	1
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	morphine	1	N02AA01	7	1
36628	Clinical practice guideline for type 2 diabetes	morphine	1	N02AA01	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	morphine	7	N02AA01	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	morphine	2	N02AA01	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	morphine	1	N02AA01	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	hydromorphone	4	N02AA03	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	oxycodone	3	N02AA05	7	1
36628	Clinical practice guideline for type 2 diabetes	oxycodone	1	N02AA05	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	oxycodone	5	N02AA05	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	oxycodone	1	N02AA05	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	tramadol	7	N02AX02	7	1
36628	Clinical practice guideline for type 2 diabetes	tramadol	1	N02AX02	7	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	tramadol	3	N02AX02	7	1
46422	"American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis of the knee, 2nd edition"	tramadol	1	N02AX02	7	1
47806	Medical management of adults with osteoarthritis	tramadol	1	N02AX02	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	tramadol	1	N02AX02	7	1
48530	VA/DoD clinical practice guideline for the non-surgical management of hip and knee osteoarthritis	tramadol	3	N02AX02	7	1
24171	Acute medical and surgical management. In: Clinical guidelines for stroke management 2010	paracetamol	1	N02BE01	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	paracetamol	2	N02BE01	7	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	paracetamol	1	N02BE01	7	1
34827	Hip fracture. The management of hip fracture in adults	paracetamol	5	N02BE01	7	1
38409	Lower limb peripheral arterial disease: diagnosis and management	paracetamol	1	N02BE01	7	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	paracetamol	2	N02BE01	7	1
47862	Osteoarthritis. Care and management in adults	paracetamol	9	N02BE01	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	paracetamol	2	N02BE01	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	antiepileptics	1	N03	3	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	phenytoin	1	N03AB02	7	0
36825	Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\'s Multidisciplinary Consensus Conference	phenytoin	1	N03AB02	7	0
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	phenytoin	1	N03AB02	7	0
34900	Late (complicated) Parkinson\'s disease	clonazepam	1	N03AE01	7	1
47315	Adult depression in primary care	clonazepam	1	N03AE01	7	1
23849	"Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline"	carbamazepine	1	N03AF01	7	1
24174	Managing complications. In: Clinical guidelines for stroke management 2010	carbamazepine	1	N03AF01	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	carbamazepine	1	N03AF01	7	1
34113	Cardiometabolic risk management guidelines in primary care	carbamazepine	1	N03AF01	7	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	carbamazepine	1	N03AF01	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	carbamazepine	1	N03AF01	7	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	carbamazepine	1	N03AF01	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	oxcarbazepine	2	N03AF02	7	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	valproic acid	2	N03AG01	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	aminobutyric acid	1	N03AG03	7	1
47315	Adult depression in primary care	aminobutyric acid	1	N03AG03	7	1
23849	"Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline"	lamotrigine	1	N03AX09	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	lamotrigine	1	N03AX09	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	lamotrigine	2	N03AX09	7	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	lamotrigine	25	N03AX09	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	topiramate	2	N03AX11	7	1
48461	VA/DoD clinical practice guideline for screening and management of overweight and obesity	topiramate	2	N03AX11	7	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	topiramate	1	N03AX11	7	1
16394	Management of diabetes. A national clinical guideline	gabapentin	2	N03AX12	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	gabapentin	4	N03AX12	7	1
36628	Clinical practice guideline for type 2 diabetes	gabapentin	1	N03AX12	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	gabapentin	1	N03AX12	7	1
47315	Adult depression in primary care	gabapentin	1	N03AX12	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	gabapentin	1	N03AX12	7	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	gabapentin	1	N03AX12	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	levetiracetam	1	N03AX14	7	1
16394	Management of diabetes. A national clinical guideline	pregabalin	1	N03AX16	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	pregabalin	3	N03AX16	7	1
36628	Clinical practice guideline for type 2 diabetes	pregabalin	1	N03AX16	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	pregabalin	1	N03AX16	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	lacosamide	2	N03AX18	7	1
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	anticholinergic agents	1	N04A	4	1
6382	"Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology"	anticholinergic agents	3	N04A	4	1
32493	Parkinson\'s disease in the long-term care setting	levodopa	7	N04BA01	7	1
34900	Late (complicated) Parkinson\'s disease	levodopa	21	N04BA01	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	levodopa	1	N04BA01	7	1
48285	ACR Appropriateness Criteria&amp;reg; dementia and movement disorders	levodopa	4	N04BA01	7	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	amantadine	2	N04BB01	7	1
34900	Late (complicated) Parkinson\'s disease	amantadine	6	N04BB01	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	amantadine	1	N04BB01	7	1
32493	Parkinson\'s disease in the long-term care setting	dopamine agonists	1	N04BC	5	1
34900	Late (complicated) Parkinson\'s disease	dopamine agonists	7	N04BC	5	1
34900	Late (complicated) Parkinson\'s disease	pergolide	2	N04BC02	7	1
34900	Late (complicated) Parkinson\'s disease	ropinirole	1	N04BC04	7	1
34900	Late (complicated) Parkinson\'s disease	pramipexole	1	N04BC05	7	1
34900	Late (complicated) Parkinson\'s disease	rotigotine	1	N04BC09	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	selegiline	2	N04BD01	7	1
32493	Parkinson\'s disease in the long-term care setting	selegiline	1	N04BD01	7	1
34900	Late (complicated) Parkinson\'s disease	selegiline	1	N04BD01	7	1
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	selegiline	1	N04BD01	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	selegiline	2	N04BD01	7	1
32493	Parkinson\'s disease in the long-term care setting	rasagiline	1	N04BD02	7	1
34900	Late (complicated) Parkinson\'s disease	rasagiline	2	N04BD02	7	1
34900	Late (complicated) Parkinson\'s disease	tolcapone	1	N04BX01	7	1
34900	Late (complicated) Parkinson\'s disease	entacapone	2	N04BX02	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	antipsychotics	1	N05A	4	1
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	antipsychotics	1	N05A	4	1
34900	Late (complicated) Parkinson\'s disease	antipsychotics	3	N05A	4	1
36906	Prevention of falls (acute care). Health care protocol	antipsychotics	2	N05A	4	1
37707	AGS/BGS clinical practice guideline: prevention of falls in older persons	antipsychotics	2	N05A	4	1
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	antipsychotics	1	N05A	4	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	antipsychotics	1	N05A	4	1
39432	Diagnosis and treatment of depression in adults: 2012 clinical practice guideline	antipsychotics	2	N05A	4	1
43922	Depression in older adults. In: Evidence-based geriatric nursing protocols for best practice	antipsychotics	1	N05A	4	1
44984	Bathing persons with dementia	antipsychotics	1	N05A	4	1
46654	Management of overweight and obesity in the adult	antipsychotics	1	N05A	4	1
47315	Adult depression in primary care	antipsychotics	1	N05A	4	1
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	antipsychotics	1	N05A	4	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	antipsychotics	7	N05A	4	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	antipsychotics	7	N05A	4	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	fluphenazine	2	N05AB02	7	1
34900	Late (complicated) Parkinson\'s disease	prochlorperazine	1	N05AB04	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	haloperidol	2	N05AD01	7	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	haloperidol	4	N05AD01	7	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	clozapine	1	N05AH02	7	1
34900	Late (complicated) Parkinson\'s disease	clozapine	3	N05AH02	7	1
34900	Late (complicated) Parkinson\'s disease	olanzapine	1	N05AH03	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	olanzapine	1	N05AH03	7	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	olanzapine	19	N05AH03	7	1
34900	Late (complicated) Parkinson\'s disease	quetiapine	3	N05AH04	7	1
47315	Adult depression in primary care	quetiapine	1	N05AH04	7	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	quetiapine	12	N05AH04	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	lithium	2	N05AN01	7	1
34113	Cardiometabolic risk management guidelines in primary care	lithium	1	N05AN01	7	1
39432	Diagnosis and treatment of depression in adults: 2012 clinical practice guideline	lithium	1	N05AN01	7	1
43863	Clinical practice guidelines: depression in adolescents and young adults	lithium	1	N05AN01	7	1
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	lithium	2	N05AN01	7	1
47315	Adult depression in primary care	lithium	6	N05AN01	7	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	lithium	49	N05AN01	7	1
34900	Late (complicated) Parkinson\'s disease	risperidone	1	N05AX08	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	risperidone	3	N05AX08	7	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	risperidone	4	N05AX08	7	1
34900	Late (complicated) Parkinson\'s disease	aripiprazole	1	N05AX12	7	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	aripiprazole	2	N05AX12	7	1
34900	Late (complicated) Parkinson\'s disease	anxiolytics	1	N05B	4	1
37707	AGS/BGS clinical practice guideline: prevention of falls in older persons	anxiolytics	1	N05B	4	1
47315	Adult depression in primary care	anxiolytics	1	N05B	4	1
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	anxiolytics	1	N05B	4	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	diazepam	1	N05BA01	7	1
33192	Acute coronary syndrome and myocardial infarction	diazepam	2	N05BA01	7	1
36906	Prevention of falls (acute care). Health care protocol	diazepam	1	N05BA01	7	1
36906	Prevention of falls (acute care). Health care protocol	lorazepam	1	N05BA06	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	lorazepam	1	N05BA06	7	1
47315	Adult depression in primary care	alprazolam	1	N05BA12	7	1
36906	Prevention of falls (acute care). Health care protocol	meprobamate	1	N05BC01	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	buspirone	1	N05BE01	7	1
47315	Adult depression in primary care	buspirone	2	N05BE01	7	1
36906	Prevention of falls (acute care). Health care protocol	midazolam	1	N05CD08	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	midazolam	1	N05CD08	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	zolpidem	1	N05CF02	7	1
36906	Prevention of falls (acute care). Health care protocol	zolpidem	3	N05CF02	7	1
47315	Adult depression in primary care	zolpidem	1	N05CF02	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	eszopiclone	1	N05CF04	7	1
47315	Adult depression in primary care	eszopiclone	1	N05CF04	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	melatonin	1	N05CH01	7	1
16394	Management of diabetes. A national clinical guideline	antidepressants	1	N06A	4	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	antidepressants	1	N06A	4	1
23849	"Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline"	antidepressants	1	N06A	4	1
23902	Nonpharmacologic management and health care maintenance of patients with chronic heart failure: HFSA 2010 comprehensive heart failure practice guideline	antidepressants	1	N06A	4	1
24127	AAFP guideline for the detection and management of post-myocardial infarction depression	antidepressants	3	N06A	4	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	antidepressants	8	N06A	4	1
24174	Managing complications. In: Clinical guidelines for stroke management 2010	antidepressants	3	N06A	4	1
32668	Depression in the long term care setting	antidepressants	3	N06A	4	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	antidepressants	2	N06A	4	1
34094	Cross-continuum topics in stroke management. In: Canadian best practice recommendations for stroke care	antidepressants	2	N06A	4	1
34113	Cardiometabolic risk management guidelines in primary care	antidepressants	1	N06A	4	1
34265	Depression and mania in patients with HIV/AIDS	antidepressants	6	N06A	4	1
34406	Depression	antidepressants	2	N06A	4	1
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	antidepressants	1	N06A	4	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	antidepressants	1	N06A	4	1
34828	Common mental health disorders. Identification and pathways to care	antidepressants	1	N06A	4	1
34900	Late (complicated) Parkinson\'s disease	antidepressants	7	N06A	4	1
36628	Clinical practice guideline for type 2 diabetes	antidepressants	1	N06A	4	1
36906	Prevention of falls (acute care). Health care protocol	antidepressants	4	N06A	4	1
37707	AGS/BGS clinical practice guideline: prevention of falls in older persons	antidepressants	2	N06A	4	1
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	antidepressants	1	N06A	4	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	antidepressants	1	N06A	4	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	antidepressants	1	N06A	4	1
39432	Diagnosis and treatment of depression in adults: 2012 clinical practice guideline	antidepressants	16	N06A	4	1
43863	Clinical practice guidelines: depression in adolescents and young adults	antidepressants	1	N06A	4	1
46654	Management of overweight and obesity in the adult	antidepressants	1	N06A	4	1
47315	Adult depression in primary care	antidepressants	27	N06A	4	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	antidepressants	4	N06A	4	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	desipramine	2	N06AA01	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	desipramine	1	N06AA01	7	1
47315	Adult depression in primary care	desipramine	2	N06AA01	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	imipramine	2	N06AA02	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	clomipramine	1	N06AA04	7	1
23849	"Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline"	amitriptyline	2	N06AA09	7	1
24174	Managing complications. In: Clinical guidelines for stroke management 2010	amitriptyline	1	N06AA09	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	amitriptyline	4	N06AA09	7	1
47315	Adult depression in primary care	amitriptyline	2	N06AA09	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	nortriptyline	2	N06AA10	7	1
24172	Secondary prevention. In: Clinical guidelines for stroke management 2010	nortriptyline	1	N06AA10	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	nortriptyline	2	N06AA10	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	nortriptyline	1	N06AA10	7	1
47315	Adult depression in primary care	nortriptyline	2	N06AA10	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	maprotiline	1	N06AA21	7	1
23902	Nonpharmacologic management and health care maintenance of patients with chronic heart failure: HFSA 2010 comprehensive heart failure practice guideline	selective serotonin reuptake inhibitors	1	N06AB	5	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	selective serotonin reuptake inhibitors	1	N06AB	5	1
32599	Dementia. Diagnosis and treatment	selective serotonin reuptake inhibitors	1	N06AB	5	1
32668	Depression in the long term care setting	selective serotonin reuptake inhibitors	1	N06AB	5	1
34094	Cross-continuum topics in stroke management. In: Canadian best practice recommendations for stroke care	selective serotonin reuptake inhibitors	2	N06AB	5	1
34265	Depression and mania in patients with HIV/AIDS	selective serotonin reuptake inhibitors	1	N06AB	5	1
38410	Osteoporosis: assessing the risk of fragility fracture	selective serotonin reuptake inhibitors	1	N06AB	5	1
38470	EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia	selective serotonin reuptake inhibitors	1	N06AB	5	1
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	selective serotonin reuptake inhibitors	1	N06AB	5	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	selective serotonin reuptake inhibitors	1	N06AB	5	1
39432	Diagnosis and treatment of depression in adults: 2012 clinical practice guideline	selective serotonin reuptake inhibitors	1	N06AB	5	1
43860	"Osteoporosis. In: Guidelines for preventive activities in general practice, 8th edition"	selective serotonin reuptake inhibitors	1	N06AB	5	1
46241	Stable coronary artery disease	selective serotonin reuptake inhibitors	1	N06AB	5	1
46654	Management of overweight and obesity in the adult	selective serotonin reuptake inhibitors	1	N06AB	5	1
47315	Adult depression in primary care	selective serotonin reuptake inhibitors	3	N06AB	5	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	selective serotonin reuptake inhibitors	1	N06AB	5	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	fluoxetine	2	N06AB03	7	1
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	fluoxetine	1	N06AB03	7	1
39432	Diagnosis and treatment of depression in adults: 2012 clinical practice guideline	fluoxetine	1	N06AB03	7	1
43863	Clinical practice guidelines: depression in adolescents and young adults	fluoxetine	1	N06AB03	7	1
47315	Adult depression in primary care	fluoxetine	2	N06AB03	7	1
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	fluoxetine	11	N06AB03	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	citalopram	1	N06AB04	7	1
39432	Diagnosis and treatment of depression in adults: 2012 clinical practice guideline	citalopram	1	N06AB04	7	1
47315	Adult depression in primary care	citalopram	8	N06AB04	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	citalopram	1	N06AB04	7	1
39432	Diagnosis and treatment of depression in adults: 2012 clinical practice guideline	paroxetine	1	N06AB05	7	1
46240	Prevention and management of obesity for adults	sertraline	1	N06AB06	7	1
47315	Adult depression in primary care	sertraline	3	N06AB06	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	sertraline	1	N06AB06	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	escitalopram	1	N06AB10	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	isocarboxazid	1	N06AF01	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	phenelzine	1	N06AF03	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	tranylcypromine	1	N06AF04	7	
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	trazodone	1	N06AX05	7	1
32599	Dementia. Diagnosis and treatment	trazodone	1	N06AX05	7	1
32668	Depression in the long term care setting	trazodone	1	N06AX05	7	1
47315	Adult depression in primary care	trazodone	1	N06AX05	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	trazodone	2	N06AX05	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	mirtazapine	1	N06AX11	7	1
32668	Depression in the long term care setting	mirtazapine	1	N06AX11	7	1
34900	Late (complicated) Parkinson\'s disease	mirtazapine	1	N06AX11	7	1
47315	Adult depression in primary care	mirtazapine	5	N06AX11	7	1
14329	Identification and management of familial hypercholesterolaemia	bupropion	2	N06AX12	7	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	bupropion	1	N06AX12	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	bupropion	4	N06AX12	7	1
24172	Secondary prevention. In: Clinical guidelines for stroke management 2010	bupropion	1	N06AX12	7	1
32668	Depression in the long term care setting	bupropion	1	N06AX12	7	1
34087	Prevention of stroke. In: Canadian best practice recommendations for stroke care	bupropion	1	N06AX12	7	1
39432	Diagnosis and treatment of depression in adults: 2012 clinical practice guideline	bupropion	1	N06AX12	7	1
46240	Prevention and management of obesity for adults	bupropion	1	N06AX12	7	1
47315	Adult depression in primary care	bupropion	4	N06AX12	7	1
47543	Diagnosis and treatment of osteoporosis	bupropion	1	N06AX12	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	bupropion	1	N06AX12	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	bupropion	1	N06AX12	7	1
16394	Management of diabetes. A national clinical guideline	venlafaxine	1	N06AX16	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	venlafaxine	1	N06AX16	7	1
24174	Managing complications. In: Clinical guidelines for stroke management 2010	venlafaxine	1	N06AX16	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	venlafaxine	5	N06AX16	7	1
34900	Late (complicated) Parkinson\'s disease	venlafaxine	1	N06AX16	7	1
39432	Diagnosis and treatment of depression in adults: 2012 clinical practice guideline	venlafaxine	1	N06AX16	7	1
46240	Prevention and management of obesity for adults	venlafaxine	1	N06AX16	7	1
47315	Adult depression in primary care	venlafaxine	3	N06AX16	7	1
34900	Late (complicated) Parkinson\'s disease	reboxetine	1	N06AX18	7	1
16394	Management of diabetes. A national clinical guideline	duloxetine	1	N06AX21	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	duloxetine	3	N06AX21	7	1
36628	Clinical practice guideline for type 2 diabetes	duloxetine	1	N06AX21	7	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	duloxetine	3	N06AX21	7	1
47315	Adult depression in primary care	duloxetine	3	N06AX21	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	duloxetine	1	N06AX21	7	1
48530	VA/DoD clinical practice guideline for the non-surgical management of hip and knee osteoarthritis	duloxetine	1	N06AX21	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	desvenlafaxine	1	N06AX23	7	1
47315	Adult depression in primary care	desvenlafaxine	1	N06AX23	7	1
15695	Putting evidence into practice: interventions for depression	methylphenidate	1	N06BA04	7	1
34900	Late (complicated) Parkinson\'s disease	methylphenidate	1	N06BA04	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	methylphenidate	1	N06BA04	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	methylphenidate	1	N06BA04	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	pemoline	1	N06BA05	7	0
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	modafinil	1	N06BA07	7	1
34900	Late (complicated) Parkinson\'s disease	modafinil	1	N06BA07	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	modafinil	1	N06BA07	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	modafinil	1	N06BA07	7	1
34286	"Osteoporosis: diagnosis, treatment, and fracture prevention"	caffeine	1	N06BC01	7	1
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	caffeine	2	N06BC01	7	1
34824	Hypertension. Clinical management of primary hypertension in adults	caffeine	1	N06BC01	7	1
34900	Late (complicated) Parkinson\'s disease	caffeine	1	N06BC01	7	1
34968	American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis	caffeine	1	N06BC01	7	1
39338	Screening for cardiovascular disease and risk factors	caffeine	1	N06BC01	7	1
43860	"Osteoporosis. In: Guidelines for preventive activities in general practice, 8th edition"	caffeine	1	N06BC01	7	1
43916	Age-related changes in health. In: Evidence-based geriatric nursing protocols for best practice	caffeine	1	N06BC01	7	1
46239	Healthy lifestyles	caffeine	1	N06BC01	7	1
48333	Atrial fibrillation: the management of atrial fibrillation	caffeine	1	N06BC01	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	propentofylline	2	N06BC02	7	1
24173	Rehabilitation. In: Clinical guidelines for stroke management 2010	piracetam	1	N06BX03	7	1
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	piracetam	1	N06BX03	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	piracetam	2	N06BX03	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	citicoline	3	N06BX06	7	
34900	Late (complicated) Parkinson\'s disease	tacrine	1	N06DA01	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	donepezil	1	N06DA02	7	1
34094	Cross-continuum topics in stroke management. In: Canadian best practice recommendations for stroke care	donepezil	2	N06DA02	7	1
34279	"Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer\'s disease"	donepezil	4	N06DA02	7	1
34900	Late (complicated) Parkinson\'s disease	donepezil	2	N06DA02	7	1
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	donepezil	1	N06DA02	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	donepezil	12	N06DA02	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	rivastigmine	1	N06DA03	7	1
34279	"Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer\'s disease"	rivastigmine	4	N06DA03	7	1
34900	Late (complicated) Parkinson\'s disease	rivastigmine	2	N06DA03	7	1
38470	EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia	rivastigmine	4	N06DA03	7	1
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	rivastigmine	1	N06DA03	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	rivastigmine	10	N06DA03	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	galantamine	1	N06DA04	7	1
34094	Cross-continuum topics in stroke management. In: Canadian best practice recommendations for stroke care	galantamine	2	N06DA04	7	1
34279	"Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer\'s disease"	galantamine	4	N06DA04	7	1
34900	Late (complicated) Parkinson\'s disease	galantamine	1	N06DA04	7	1
38470	EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia	galantamine	1	N06DA04	7	1
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	galantamine	1	N06DA04	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	galantamine	5	N06DA04	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	donepezil and memantine	1	N06DA52	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	memantine	1	N06DX01	7	1
32599	Dementia. Diagnosis and treatment	memantine	1	N06DX01	7	1
34279	"Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer\'s disease"	memantine	3	N06DX01	7	1
34900	Late (complicated) Parkinson\'s disease	memantine	1	N06DX01	7	1
38470	EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia	memantine	4	N06DX01	7	1
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	memantine	1	N06DX01	7	1
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	memantine	20	N06DX01	7	1
15711	Clinical practice guideline on the management of lipids as a cardiovascular risk factor	combinations	1	N06DX30	7	0
15712	Clinical practice guidelines on arterial hypertension. 2007 update	combinations	1	N06DX30	7	0
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	combinations	1	N06DX30	7	0
23910	Managing patients with hypertension and heart failure: HFSA 2010 comprehensive heart failure practice guideline	combinations	1	N06DX30	7	0
24172	Secondary prevention. In: Clinical guidelines for stroke management 2010	combinations	1	N06DX30	7	0
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	combinations	1	N06DX30	7	0
24599	Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 revision	combinations	1	N06DX30	7	0
25661	Recommendations from the EGAPP Working Group: genomic profiling to assess cardiovascular risk to improve cardiovascular health	combinations	1	N06DX30	7	0
32668	Depression in the long term care setting	combinations	1	N06DX30	7	0
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	combinations	1	N06DX30	7	0
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	combinations	1	N06DX30	7	0
36874	Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline	combinations	1	N06DX30	7	0
37691	Allergen immunotherapy: a practice parameter third update	combinations	1	N06DX30	7	0
38244	KDIGO clinical practice guideline for glomerulonephritis	combinations	1	N06DX30	7	0
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	combinations	3	N06DX30	7	0
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	combinations	1	N06DX30	7	0
39404	Critical illness evidence-based nutrition practice guideline	combinations	1	N06DX30	7	0
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	combinations	1	N06DX30	7	0
47315	Adult depression in primary care	combinations	1	N06DX30	7	0
47568	World Gastroenterology Organisation global guideline: obesity	combinations	1	N06DX30	7	0
47783	Lipid management in adults	combinations	4	N06DX30	7	0
48117	Guidelines for the management of absolute cardiovascular disease risk	combinations	1	N06DX30	7	0
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	pilocarpine	1	N07AX01	7	1
14329	Identification and management of familial hypercholesterolaemia	nicotine	2	N07BA01	7	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	nicotine	1	N07BA01	7	1
24172	Secondary prevention. In: Clinical guidelines for stroke management 2010	nicotine	2	N07BA01	7	1
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	nicotine	2	N07BA01	7	1
32419	(1) Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD). (2) Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD) 2010 supplement	nicotine	1	N07BA01	7	1
32491	COPD management in the long-term care setting	nicotine	1	N07BA01	7	1
33192	Acute coronary syndrome and myocardial infarction	nicotine	1	N07BA01	7	1
34087	Prevention of stroke. In: Canadian best practice recommendations for stroke care	nicotine	1	N07BA01	7	1
37694	Assessing heart failure in long term care facilities	nicotine	1	N07BA01	7	1
38897	Chronic obstructive pulmonary disease (COPD)	nicotine	1	N07BA01	7	1
43853	"Prevention of chronic disease. In: Guidelines for preventive activities in general practice, 8th edition"	nicotine	6	N07BA01	7	1
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	nicotine	1	N07BA01	7	1
47543	Diagnosis and treatment of osteoporosis	nicotine	1	N07BA01	7	1
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	nicotine	2	N07BA01	7	1
48117	Guidelines for the management of absolute cardiovascular disease risk	nicotine	2	N07BA01	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	nicotine	1	N07BA01	7	1
48544	Diagnosis and management of type 2 diabetes mellitus in adults	nicotine	1	N07BA01	7	1
14329	Identification and management of familial hypercholesterolaemia	varenicline	2	N07BA03	7	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	varenicline	4	N07BA03	7	1
34087	Prevention of stroke. In: Canadian best practice recommendations for stroke care	varenicline	1	N07BA03	7	1
47315	Adult depression in primary care	varenicline	2	N07BA03	7	1
47543	Diagnosis and treatment of osteoporosis	varenicline	1	N07BA03	7	1
48221	Secondary prevention of ischemic heart disease and stroke in adults	varenicline	1	N07BA03	7	1
48406	Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease	varenicline	1	N07BA03	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	methadone	8	N07BC02	7	1
34900	Late (complicated) Parkinson\'s disease	cinnarizine	1	N07CA02	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	antimalarials	2	P01B	4	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	antimalarials	2	P01B	4	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	chloroquine	1	P01BA01	7	1
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	hydroxychloroquine	1	P01BA02	7	1
36892	2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis	hydroxychloroquine	1	P01BA02	7	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	hydroxychloroquine	1	P01BA02	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	hydroxychloroquine	2	P01BA02	7	1
39244	"Rheumatoid arthritis: diagnosis, management and monitoring"	hydroxychloroquine	1	P01BA02	7	1
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	hydroxychloroquine	1	P01BA02	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	levamisole	3	P02CE01	7	1
35922	Consultation and referral guidelines citing the evidence: how the allergist/immunologist can help	nedocromil	1	R01AC07	7	1
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	nedocromil	1	R01AC07	7	1
47572	Asthma. In: Pulmonary (acute &amp;amp; chronic)&lt;/div&gt;	nedocromil	2	R01AC07	7	1
24599	Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 revision	ipratropium bromide	3	R01AX03	7	1
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	ipratropium bromide	1	R01AX03	7	1
38255	Diagnosis and management of asthma	ipratropium bromide	3	R01AX03	7	1
38255	Diagnosis and management of asthma	sympathomimetics	1	R01BA	5	1
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	pirbuterol	1	R03AC08	7	1
32491	COPD management in the long-term care setting	salmeterol	1	R03AC12	7	1
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	salmeterol	3	R03AC12	7	1
32491	COPD management in the long-term care setting	formoterol	1	R03AC13	7	1
32491	COPD management in the long-term care setting	tiotropium bromide	2	R03BB04	7	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	theophylline	15	R03DA04	7	1
32491	COPD management in the long-term care setting	theophylline	1	R03DA04	7	1
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	theophylline	1	R03DA04	7	1
38255	Diagnosis and management of asthma	theophylline	1	R03DA04	7	1
38897	Chronic obstructive pulmonary disease (COPD)	theophylline	1	R03DA04	7	1
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	theophylline	5	R03DA04	7	1
47572	Asthma. In: Pulmonary (acute &amp;amp; chronic)&lt;/div&gt;	theophylline	7	R03DA04	7	1
48951	VA/DoD clinical practice guideline for the management of chronic kidney disease in primary care	theophylline	1	R03DA04	7	1
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	theophylline	1	R03DA04	7	1
49133	Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society guideline	theophylline	1	R03DA04	7	1
24599	Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 revision	montelukast	2	R03DC03	7	1
38255	Diagnosis and management of asthma	montelukast	1	R03DC03	7	1
37691	Allergen immunotherapy: a practice parameter third update	omalizumab	3	R03DX05	7	1
38693	General principles for the diagnosis and management of asthma	omalizumab	1	R03DX05	7	1
45128	Omalizumab for treating severe persistent allergic asthma (review of technology appraisal guidance 133 and 201)	omalizumab	3	R03DX05	7	1
47572	Asthma. In: Pulmonary (acute &amp;amp; chronic)&lt;/div&gt;	omalizumab	6	R03DX05	7	1
48457	"International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma"	omalizumab	4	R03DX05	7	1
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	roflumilast	3	R03DX07	7	1
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	roflumilast	1	R03DX07	7	1
49133	Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society guideline	roflumilast	1	R03DX07	7	1
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	guaifenesin	1	R05CA03	7	1
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	mucolytics	1	R05CB	5	1
48951	VA/DoD clinical practice guideline for the management of chronic kidney disease in primary care	acetylcysteine	1	R05CB01	7	1
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	acetylcysteine	1	R05CB01	7	1
49133	Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society guideline	acetylcysteine	1	R05CB01	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	codeine	1	R05DA04	7	1
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	codeine	2	R05DA04	7	1
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	dextromethorphan	5	R05DA09	7	1
34113	Cardiometabolic risk management guidelines in primary care	cyproheptadine	1	R06AX02	7	1
24599	Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 revision	astemizole	1	R06AX11	7	1
24599	Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 revision	terfenadine	1	R06AX12	7	1
24599	Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 revision	ketotifen	1	R06AX17	7	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	respiratory stimulants	1	R07AB	5	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	doxapram	1	R07AB01	7	1
38255	Diagnosis and management of asthma	nitric oxide	3	R07AX01	7	1
48457	"International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma"	nitric oxide	1	R07AX01	7	1
48533	"Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath"	nitric oxide	1	R07AX01	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	interferon	2	S01AD05	7	1
34265	Depression and mania in patients with HIV/AIDS	interferon	4	S01AD05	7	1
36892	2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis	interferon	1	S01AD05	7	1
37288	Guidelines for the prevention and management of &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; infection and disease in adult patients with chronic kidney disease	interferon	1	S01AD05	7	1
38244	KDIGO clinical practice guideline for glomerulonephritis	interferon	3	S01AD05	7	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	interferon	1	S01AD05	7	1
47315	Adult depression in primary care	interferon	2	S01AD05	7	1
32645	ACR Appropriateness Criteria&amp;reg; cerebrovascular disease	acetazolamide	6	S01EC01	7	1
48285	ACR Appropriateness Criteria&amp;reg; dementia and movement disorders	acetazolamide	2	S01EC01	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	corticosteroids	1	S02BA	5	1
15488	American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of glenohumeral joint osteoarthritis	corticosteroids	1	S02BA	5	1
16319	Asthma	corticosteroids	2	S02BA	5	1
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	corticosteroids	11	S02BA	5	1
23824	ACR Appropriateness Criteria&amp;reg; osteoporosis and bone mineral density	corticosteroids	4	S02BA	5	1
23860	Chronic obstructive pulmonary disease	corticosteroids	3	S02BA	5	1
24171	Acute medical and surgical management. In: Clinical guidelines for stroke management 2010	corticosteroids	1	S02BA	5	1
24599	Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 revision	corticosteroids	2	S02BA	5	1
32419	(1) Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD). (2) Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD) 2010 supplement	corticosteroids	3	S02BA	5	1
32491	COPD management in the long-term care setting	corticosteroids	2	S02BA	5	1
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	corticosteroids	1	S02BA	5	1
34091	Stroke rehabilitation. In: Canadian best practice recommendations for stroke care	corticosteroids	1	S02BA	5	1
34205	"Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society"	corticosteroids	4	S02BA	5	1
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	corticosteroids	1	S02BA	5	1
34950	Management of early rheumatoid arthritis. A national clinical guideline	corticosteroids	2	S02BA	5	1
35255	Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline	corticosteroids	1	S02BA	5	1
35922	Consultation and referral guidelines citing the evidence: how the allergist/immunologist can help	corticosteroids	3	S02BA	5	1
36825	Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\'s Multidisciplinary Consensus Conference	corticosteroids	2	S02BA	5	1
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	corticosteroids	1	S02BA	5	1
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	corticosteroids	2	S02BA	5	1
37691	Allergen immunotherapy: a practice parameter third update	corticosteroids	2	S02BA	5	1
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	corticosteroids	3	S02BA	5	1
38244	KDIGO clinical practice guideline for glomerulonephritis	corticosteroids	42	S02BA	5	1
38255	Diagnosis and management of asthma	corticosteroids	24	S02BA	5	1
38693	General principles for the diagnosis and management of asthma	corticosteroids	3	S02BA	5	1
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	corticosteroids	3	S02BA	5	1
38897	Chronic obstructive pulmonary disease (COPD)	corticosteroids	3	S02BA	5	1
43860	"Osteoporosis. In: Guidelines for preventive activities in general practice, 8th edition"	corticosteroids	1	S02BA	5	1
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	corticosteroids	9	S02BA	5	1
45128	Omalizumab for treating severe persistent allergic asthma (review of technology appraisal guidance 133 and 201)	corticosteroids	3	S02BA	5	1
46422	"American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis of the knee, 2nd edition"	corticosteroids	1	S02BA	5	1
46654	Management of overweight and obesity in the adult	corticosteroids	1	S02BA	5	1
47151	Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation	corticosteroids	1	S02BA	5	1
47543	Diagnosis and treatment of osteoporosis	corticosteroids	1	S02BA	5	1
47572	Asthma. In: Pulmonary (acute &amp;amp; chronic)&lt;/div&gt;	corticosteroids	17	S02BA	5	1
47804	Management and prevention of osteoporosis	corticosteroids	1	S02BA	5	1
47806	Medical management of adults with osteoarthritis	corticosteroids	1	S02BA	5	1
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	corticosteroids	1	S02BA	5	1
48406	Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease	corticosteroids	1	S02BA	5	1
48457	"International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma"	corticosteroids	3	S02BA	5	1
48530	VA/DoD clinical practice guideline for the non-surgical management of hip and knee osteoarthritis	corticosteroids	1	S02BA	5	1
48533	"Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath"	corticosteroids	1	S02BA	5	1
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	corticosteroids	3	S02BA	5	1
49133	Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society guideline	corticosteroids	3	S02BA	5	1
6382	"Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology"	corticosteroids	3	S02BA	5	1
24599	Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 revision	allergens	8	V01	3	0
35922	Consultation and referral guidelines citing the evidence: how the allergist/immunologist can help	allergens	4	V01	3	0
36826	"Occupational asthma: prevention, identification &amp;amp; management: systematic review &amp;amp; recommendations"	allergens	1	V01	3	0
37691	Allergen immunotherapy: a practice parameter third update	allergens	23	V01	3	0
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	allergens	2	V01	3	0
38255	Diagnosis and management of asthma	allergens	11	V01	3	0
38693	General principles for the diagnosis and management of asthma	allergens	1	V01	3	0
47572	Asthma. In: Pulmonary (acute &amp;amp; chronic)&lt;/div&gt;	allergens	5	V01	3	0
37691	Allergen immunotherapy: a practice parameter third update	allergen extracts	10	V01AA	5	0
37691	Allergen immunotherapy: a practice parameter third update	grass pollen	1	V01AA02	7	0
24599	Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 revision	house dust mites	7	V01AA03	7	0
16394	Management of diabetes. A national clinical guideline	protamine	3	V03AB14	7	1
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	protamine	1	V03AB14	7	1
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	protamine	1	V03AB14	7	1
34113	Cardiometabolic risk management guidelines in primary care	protamine	2	V03AB14	7	1
39247	"2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design"	protamine	1	V03AB14	7	1
47068	Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes	protamine	1	V03AB14	7	1
47865	Clinical practice guideline for diabetes mellitus type 1	protamine	1	V03AB14	7	1
47898	Diabetes and pregnancy: an Endocrine Society clinical practice guideline	protamine	1	V03AB14	7	1
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	methionine	1	V03AB26	7	0
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	methionine	1	V03AB26	7	0
34094	Cross-continuum topics in stroke management. In: Canadian best practice recommendations for stroke care	cholinesterase	1	V03AB29	7	1
34900	Late (complicated) Parkinson\'s disease	cholinesterase	3	V03AB29	7	1
38470	EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia	cholinesterase	1	V03AB29	7	1
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	cholinesterase	1	V03AB29	7	1
44984	Bathing persons with dementia	cholinesterase	1	V03AB29	7	1
44088	Hyperphosphataemia in chronic kidney disease. Management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease	sevelamer	4	V03AE02	7	1
44088	Hyperphosphataemia in chronic kidney disease. Management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease	lanthanum carbonate	1	V03AE03	7	1
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	tissue adhesives	1	V03AK	5	0
10585	Acute coronary syndromes. A national clinical guideline	oxygen	2	V03AN01	7	0
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	oxygen	11	V03AN01	7	0
14328	Stroke. Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA)	oxygen	6	V03AN01	7	0
16392	Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin	oxygen	8	V03AN01	7	0
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	oxygen	47	V03AN01	7	0
23860	Chronic obstructive pulmonary disease	oxygen	17	V03AN01	7	0
23902	Nonpharmacologic management and health care maintenance of patients with chronic heart failure: HFSA 2010 comprehensive heart failure practice guideline	oxygen	2	V03AN01	7	0
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	oxygen	4	V03AN01	7	0
23992	Endotracheal suctioning of mechanically ventilated patients with artificial airways 2010	oxygen	9	V03AN01	7	0
24171	Acute medical and surgical management. In: Clinical guidelines for stroke management 2010	oxygen	5	V03AN01	7	0
24713	Coronary heart disease	oxygen	3	V03AN01	7	0
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	oxygen	1	V03AN01	7	0
32419	(1) Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD). (2) Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD) 2010 supplement	oxygen	7	V03AN01	7	0
32491	COPD management in the long-term care setting	oxygen	8	V03AN01	7	0
32645	ACR Appropriateness Criteria&amp;reg; cerebrovascular disease	oxygen	8	V03AN01	7	0
33192	Acute coronary syndrome and myocardial infarction	oxygen	7	V03AN01	7	0
34019	Wheelchair biking for the treatment of depression	oxygen	1	V03AN01	7	0
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	oxygen	1	V03AN01	7	0
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	oxygen	16	V03AN01	7	0
34090	Acute stroke management. In: Canadian best practice recommendations for stroke care	oxygen	1	V03AN01	7	0
34113	Cardiometabolic risk management guidelines in primary care	oxygen	1	V03AN01	7	0
34205	"Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society"	oxygen	6	V03AN01	7	0
34271	Rapid response team	oxygen	6	V03AN01	7	0
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	oxygen	1	V03AN01	7	0
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	oxygen	1	V03AN01	7	0
34831	Diabetic foot problems. Inpatient management of diabetic foot problems	oxygen	1	V03AN01	7	0
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	oxygen	1	V03AN01	7	0
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	oxygen	8	V03AN01	7	0
36825	Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\'s Multidisciplinary Consensus Conference	oxygen	1	V03AN01	7	0
37220	2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections	oxygen	2	V03AN01	7	0
37286	British Thoracic Society guideline for advanced diagnostic and therapeutic flexible bronchoscopy in adults	oxygen	1	V03AN01	7	0
37691	Allergen immunotherapy: a practice parameter third update	oxygen	1	V03AN01	7	0
37694	Assessing heart failure in long term care facilities	oxygen	1	V03AN01	7	0
38255	Diagnosis and management of asthma	oxygen	2	V03AN01	7	0
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	oxygen	2	V03AN01	7	0
38897	Chronic obstructive pulmonary disease (COPD)	oxygen	8	V03AN01	7	0
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	oxygen	9	V03AN01	7	0
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	oxygen	3	V03AN01	7	0
43916	Age-related changes in health. In: Evidence-based geriatric nursing protocols for best practice	oxygen	1	V03AN01	7	0
43926	"Heart failure: early recognition, and treatment of the patient at risk for hospital readmission. In: Evidence-based geriatric nursing protocols for best practice"	oxygen	2	V03AN01	7	0
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	oxygen	44	V03AN01	7	0
46241	Stable coronary artery disease	oxygen	1	V03AN01	7	0
46946	Ottawa Panel evidence-based clinical practice guidelines for aerobic walking programs in the management of osteoarthritis	oxygen	2	V03AN01	7	0
47030	Heart failure in adults	oxygen	1	V03AN01	7	0
47037	British Thoracic Society guideline on pulmonary rehabilitation in adults	oxygen	7	V03AN01	7	0
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	oxygen	1	V03AN01	7	0
47572	Asthma. In: Pulmonary (acute &amp;amp; chronic)&lt;/div&gt;	oxygen	2	V03AN01	7	0
48763	Energy expenditure: measuring resting metabolic rate (RMR) in the critically ill evidence-based nutrition practice guideline	oxygen	2	V03AN01	7	0
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	oxygen	6	V03AN01	7	0
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	carbon dioxide	1	V03AN02	7	0
24713	Coronary heart disease	carbon dioxide	1	V03AN02	7	0
33192	Acute coronary syndrome and myocardial infarction	carbon dioxide	1	V03AN02	7	0
37941	ACR Appropriateness Criteria&amp;reg; renovascular hypertension	carbon dioxide	1	V03AN02	7	0
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	carbon dioxide	2	V03AN02	7	0
47681	ACR Appropriateness Criteria&amp;reg; renal failure	carbon dioxide	1	V03AN02	7	0
48368	Guidelines for laparoscopic peritoneal dialysis access surgery	carbon dioxide	1	V03AN02	7	0
48763	Energy expenditure: measuring resting metabolic rate (RMR) in the critically ill evidence-based nutrition practice guideline	carbon dioxide	1	V03AN02	7	0
38255	Diagnosis and management of asthma	helium	1	V03AN03	7	1
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	nitrogen	1	V03AN04	7	0
23900	Evaluation of patients for ventricular dysfunction and heart failure: HFSA 2010 comprehensive heart failure practice guideline	nitrogen	1	V03AN04	7	0
23902	Nonpharmacologic management and health care maintenance of patients with chronic heart failure: HFSA 2010 comprehensive heart failure practice guideline	nitrogen	1	V03AN04	7	0
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	nitrogen	1	V03AN04	7	0
37691	Allergen immunotherapy: a practice parameter third update	nitrogen	1	V03AN04	7	0
38254	Diagnosis and initial treatment of ischemic stroke	nitrogen	1	V03AN04	7	0
38684	A.S.P.E.N. clinical guidelines: nutrition support in adult acute and chronic renal failure	nitrogen	1	V03AN04	7	0
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	nitrogen	1	V03AN04	7	0
39393	Kidney disease in HIV-infected patients	nitrogen	1	V03AN04	7	0
39404	Critical illness evidence-based nutrition practice guideline	nitrogen	1	V03AN04	7	0
46648	Diagnosis and management of adults with chronic kidney disease	nitrogen	1	V03AN04	7	0
47030	Heart failure in adults	nitrogen	2	V03AN04	7	0
47108	Adults with systolic heart failure	nitrogen	1	V03AN04	7	0
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	nitrogen	2	V03AN04	7	0
47538	A.S.P.E.N. clinical guidelines: nutrition support of hospitalized adult patients with obesity	nitrogen	1	V03AN04	7	0
47681	ACR Appropriateness Criteria&amp;reg; renal failure	nitrogen	1	V03AN04	7	0
48280	ACR Appropriateness Criteria&amp;reg; chest pain suggestive of acute coronary syndrome	nitrogen	1	V03AN04	7	0
39393	Kidney disease in HIV-infected patients	cobicistat	1	V03AX03	7	
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	cobicistat	2	V03AX03	7	
35922	Consultation and referral guidelines citing the evidence: how the allergist/immunologist can help	diagnostic agents	1	V04	3	0
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	tuberculin	2	V04CF01	7	0
36892	2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis	tuberculin	1	V04CF01	7	0
37288	Guidelines for the prevention and management of &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; infection and disease in adult patients with chronic kidney disease	tuberculin	1	V04CF01	7	0
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	tuberculin	2	V04CF01	7	0
37920	ACR Appropriateness Criteria&amp;reg; neuroendocrine imaging	thyrotropin	1	V04CJ01	7	1
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	protein supplements	1	V06B	4	0
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	protein supplements	1	V06B	4	0
46239	Healthy lifestyles	fructose	1	V06DC02	7	0
47865	Clinical practice guideline for diabetes mellitus type 1	fructose	3	V06DC02	7	0
48406	Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease	fructose	1	V06DC02	7	0
32645	ACR Appropriateness Criteria&amp;reg; cerebrovascular disease	contrast media	1	V08	3	0
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	contrast media	3	V08	3	0
37915	ACR Appropriateness Criteria&amp;reg; suspected osteomyelitis of the foot in patients with diabetes mellitus	contrast media	1	V08	3	0
37920	ACR Appropriateness Criteria&amp;reg; neuroendocrine imaging	contrast media	1	V08	3	0
37941	ACR Appropriateness Criteria&amp;reg; renovascular hypertension	contrast media	4	V08	3	0
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	contrast media	3	V08	3	0
47681	ACR Appropriateness Criteria&amp;reg; renal failure	contrast media	11	V08	3	0
48280	ACR Appropriateness Criteria&amp;reg; chest pain suggestive of acute coronary syndrome	contrast media	1	V08	3	0
48285	ACR Appropriateness Criteria&amp;reg; dementia and movement disorders	contrast media	1	V08	3	0
